10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 26, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 0-26946

INTEVAC, INC.

(Exact name of registrant as specified in its charter)

Delaware	94-3125814
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

3560 Bassett Street

Santa Clara, California 95054

(Address of principal executive office, including Zip Code)

Registrant’s telephone number, including area code: (408) 986-9888

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock ($0.001 par value)	IVAC	The Nasdaq Stock Market LLC (Nasdaq) Global Select

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒  Yes    ☐  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒  Yes    ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    ☐  Yes    ☒  No

On October 27, 2020, 23,853,623 shares of the Registrant’s Common Stock, $0.001 par value, were outstanding.

INTEVAC, INC.

INDEX

No.		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Balance Sheets		3
	Condensed Consolidated Statements of Operations		4
	Condensed Consolidated Statements of Comprehensive Income (Loss)		5
	Condensed Consolidated Statements of Cash Flows		6
	Notes to Condensed Consolidated Financial Statements		7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		33
Item 4.	Controls and Procedures		33
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings		34
Item 1A.	Risk Factors		34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		40
Item 3.	Defaults upon Senior Securities		40
Item 4.	Mine Safety Disclosures		40
Item 5.	Other Information		40
Item 6.	Exhibits		40
SIGNATURES			42

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

INTEVAC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 26, 2020			December 28, 2019
	(Unaudited)
	(In thousands, except par value)
ASSETS
Current assets:
Cash and cash equivalents	$	27,245		$	19,767
Short-term investments		18,342			16,720
Trade and other accounts receivable, net of allowances of $0 at both September 26, 2020 and at December 28, 2019		23,221			28,619
Inventories		23,638			24,907
Prepaid expenses and other current assets		2,031			1,504
Total current assets		94,477			91,517
Long-term investments		3,074			5,537
Restricted cash		787			787
Property, plant and equipment, net		11,552			11,598
Operating lease right-of-use-assets		8,739			10,279
Deferred income taxes and other long-term assets		5,740			6,604
Total assets	$	124,369		$	126,322
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current operating lease liabilities	$	2,776		$	2,524
Accounts payable		4,463			4,199
Accrued payroll and related liabilities		6,478			6,488
Other accrued liabilities		2,289			3,593
Customer advances		1,051			4,007
Total current liabilities		17,057			20,811
Noncurrent liabilities:
Noncurrent operating lease liabilities		7,516			9,532
Other long-term liabilities		688			186
Total noncurrent liabilities		8,204			9,718
Stockholders’ equity:
Common stock, $0.001 par value		24			23
Additional paid-in capital		191,976			188,290
Treasury stock, 5,087 shares at September 26, 2020 and 4,989 shares at December 28, 2019		(29,551	)		(29,158	)
Accumulated other comprehensive income		502			424
Accumulated deficit		(63,843	)		(63,786	)
Total stockholders’ equity		99,108			95,793
Total liabilities and stockholders’ equity	$	124,369		$	126,322

Note: Amounts as of December 28, 2019 are derived from the December 28, 2019 audited consolidated financial statements.

See accompanying notes to the condensed consolidated financial statements.

3

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(Unaudited)
	(In thousands, except per share amounts)
Net revenues:
Systems and components	$	15,027		$	21,090		$	51,589		$	59,965
Technology development		6,538			5,209			17,659			13,476
Total net revenues		21,565			26,299			69,248			73,441
Cost of net revenues:
Systems and components		8,389			14,180			29,969			39,741
Technology development		3,876			3,341			10,403			9,325
Total cost of net revenues		12,265			17,521			40,372			49,066
Gross profit		9,300			8,778			28,876			24,375
Operating expenses:
Research and development		3,603			3,596			10,594			11,013
Selling, general and administrative		5,845			5,615			17,426			16,720
Total operating expenses		9,448			9,211			28,020			27,733
Income (loss) from operations		(148	)		(433	)		856			(3,358	)
Interest income and other income (expense), net		8			126			212			448
Income (loss) before provision for income taxes		(140	)		(307	)		1,068			(2,910	)
Provision for income taxes		217			173			1,125			1,144
Net loss	$	(357	)	$	(480	)	$	(57	)	$	(4,054	)
Net loss per share:
Basic and Diluted	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)
Weighted average common shares outstanding:
Basic and Diluted		23,771			23,130			23,605			22,992

See accompanying notes to the condensed consolidated financial statements.

4

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(Unaudited)
	(In thousands)
Net loss	$	(357	)	$	(480	)	$	(57	)	$	(4,054	)
Other comprehensive income (loss), before tax Change in unrealized net gain on available-for-sale investments		(24	)		3			29			80
Foreign currency translation gains (losses)		124			(87	)		49			(87	)
Other comprehensive income (loss), before tax		100			(84	)		78			(7	)
Income tax (expense) benefit related to items in other comprehensive income (loss)		—			—			—			—
Other comprehensive income (loss), net of tax		100			(84	)		78			(7	)
Comprehensive income (loss)	$	(257	)	$	(564	)	$	21		$	(4,061	)

See accompanying notes to the condensed consolidated financial statements.

5

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine months ended
	September 26, 2020			September 28, 2019
	(Unaudited)
	(In thousands)
Operating activities
Net loss	$	(57	)	$	(4,054	)
Adjustments to reconcile net loss to net cash and cash equivalents provided by (used in) operating activities:
Depreciation and amortization		2,645			2,778
Net amortization (accretion) of investment premiums and discounts		(9	)		(55	)
Equity-based compensation		2,186			2,260
Straight-line rent adjustment and amortization of lease incentives		(224	)		(238	)
Change in the fair value of acquisition-related contingent consideration		—			7
Deferred income taxes		516			552
Loss on disposal of equipment		—			87
Changes in operating assets and liabilities		2,714			(2,470	)
Total adjustments		7,828			2,921
Net cash and cash equivalents provided by (used in) operating activities		7,771			(1,133	)
Investing activities
Purchases of investments		(17,071	)		(18,917	)
Proceeds from sales and maturities of investments		17,950			18,751
Purchases of leasehold improvements and equipment		(2,329	)		(3,279	)
Net cash and cash equivalents used in investing activities		(1,450	)		(3,445	)
Financing activities
Net proceeds from issuance of common stock		1,865			1,770
Common stock repurchases		(393	)		(111	)
Taxes paid related to net share settlement		(364	)		(296	)
Payment of acquisition-related contingent consideration		—			(230	)
Net cash and cash equivalents provided by financing activities		1,108			1,133
Effect of exchange rate changes on cash		49			(87	)
Net increase (decrease) in cash, cash equivalents and restricted cash		7,478			(3,532	)
Cash, cash equivalents and restricted cash at beginning of period		20,554			19,884
Cash, cash equivalents and restricted cash at end of period	$	28,032		$	16,352
Non-cash investing and financing activity
Additions to right-of-use-assets obtained from new operating lease liabilities	$	128		$	—

See accompanying notes to the condensed consolidated financial statements.

6

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Description of Business, Basis of Presentation and Significant Accounting Policy

Description of Business

Intevac, Inc. (together with its subsidiaries “Intevac,” the “Company” or “we”) is a provider of vacuum deposition equipment for a wide variety of thin-film applications, and a leading provider of digital night-vision technologies and products to the defense industry. The Company leverages its core capabilities in high-volume manufacturing of small substrates to provide process manufacturing equipment solutions to the hard disk drive (“HDD”), display cover panel (“DCP”), and photovoltaic (“PV”) solar cell industries. Intevac also provides sensors, cameras and systems for government applications such as night vision. Intevac’s customers include manufacturers of hard disk media, DCPs and solar cells as well as the U.S. government and its agencies, allies and contractors. Intevac reports two segments: Thin-film Equipment (“TFE”) and Photonics.

COVID-19 Update

In March 2020, the World Health Organization characterized the coronavirus (“COVID-19”) a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, unprecedented market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. However, we are monitoring the progression of the pandemic and its potential effect on our financial position, results of operations, and cash flows. Our factory in Singapore was given notice by the Singapore government to suspend all on-site activities on April 27, 2020. We appealed this notice and were provided an exemption on April 28, 2020. Starting May 14, 2020, we were temporarily required to limit the number of employees on site at our Singapore factory but these restrictions were lifted on June 2, 2020.

Basis of Presentation

In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac included herein have been prepared on a basis consistent with the December 28, 2019 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. Intevac’s results of operations for the three and nine months ended September 26, 2020 are not necessarily indicative of future operating results.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates.

Significant Accounting Policy

Government Grants and Credits

The Company generally records grants from governmental agencies related to income as a reduction in operating expense. Grants are recognized when there is reasonable assurance that the Company will comply with the conditions attached to the grant arrangement and the grant will be received. Reimbursements of eligible expenditures pursuant to government assistance programs are recorded as reductions of operating costs when the related costs have been incurred and there is reasonable assurance regarding collection of the claim. Grant claims not settled by the balance sheet date are recorded as receivables, provided their receipt is reasonably assured. The determination of the amount of the claim, and accordingly the receivable amount, requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. In Singapore, Intevac receives government assistance under the Job Support Scheme (“JSS”). During the quarter ended September 26, 2020, the Company received $124,000 in JSS grants, of which $72,000 is reported as a reduction of cost of net revenues, $20,000 is reported as a reduction of research and development (“R&D”) expenses and $32,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations. During the nine months ended September 26, 2020, the Company received $434,000 in JSS grants, of which $252,000 is reported as a reduction of cost of net revenues, $68,000 is reported as a reduction of R&D expenses and $114,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations.

7

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

2. Revenue

The following tables represent a disaggregation of revenue from contracts with customers for the three and nine months ended September 26, 2020 and September 28, 2019 along with the reportable segment for each category.

Major Products and Service Lines

TFE	Three Months Ended September 26, 2020								Three Months Ended September 28, 2019
	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		Total
Systems, upgrades and spare parts	$	7,601	$	—	$	131	$	7,732	$	7,737	$	—	$	8,225	$	15,962
Field service		1,635		—		—		1,635		1,109		—		45		1,154
Total TFE net revenues	$	9,236	$	—	$	131	$	9,367	$	8,846	$	—	$	8,270	$	17,116
	Nine Months Ended September 26, 2020								Nine Months Ended September 28, 2019
	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		Total
Systems, upgrades and spare parts	$	29,189	$	—	$	400	$	29,589	$	31,210	$	—	$	14,616	$	45,826
Field service		4,334		—		2		4,336		3,452		2		45		3,499
Total TFE net revenues	$	33,523	$	—	$	402	$	33,925	$	34,662	$	2	$	14,661	$	49,325

	Three Months Ended				Nine Months Ended
Photonics	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands)
Products:
Military products	$	4,947	$	3,320	$	15,758	$	8,115
Commercial products		139		81		257		581
Repair and other services		574		573		1,649		1,944
Total Photonics product net revenues		5,660		3,974		17,664		10,640
Technology development:
Firm Fixed Price (“FFP”)		5,482		3,218		15,374		7,995
Cost Plus Fixed Fee (“CPFF”)		1,056		1,991		2,285		5,479
Time and materials		—		—		—		2
Total technology development net revenues		6,538		5,209		17,659		13,476
Total Photonics net revenues	$	12,198	$	9,183	$	35,323	$	24,116

Primary Geographical Markets

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	1,764	$	12,079	$	13,843	$	478	$	9,050	$	9,528
Asia		7,536		—		7,536		16,638		—		16,638
Europe		67		119		186		—		133		133
Total net revenues	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299

8

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	2,596	$	35,060	$	37,656	$	995	$	23,578	$	24,573
Asia		31,262		—		31,262		48,330		—		48,330
Europe		67		263		330		—		538		538
Total net revenues	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

Timing of Revenue Recognition

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
Products transferred at a point in time	$	9,367	$	574	$	9,941	$	17,116	$	573	$	17,689
Products and services transferred over time		—		11,624		11,624		—		8,610		8,610
	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299
	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
Products transferred at a point in time	$	33,925	$	1,649	$	35,574	$	49,325	$	1,944	$	51,269
Products and services transferred over time		—		33,674		33,674		—		22,172		22,172
	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

The following table reflects the changes in our contract assets, which we classify as accounts receivable, unbilled or retainage, and our contract liabilities, which we classify as deferred revenue and customer advances, for the nine months ended September 26, 2020:

	September 26, 2020		December 28, 2019		Nine Months Change
	(In thousands)
TFE:
Contract assets:
Accounts receivable, unbilled	$	560	$	760	$	(200	)
Contract liabilities:
Deferred revenue	$	399	$	320	$	79
Customer advances		1,051		4,007		(2,956	)
	$	1,450	$	4,327	$	(2,877	)
Photonics:
Contract assets:
Accounts receivable, unbilled	$	3,238	$	3,210	$	28
Retainage		123		99		24
	$	3,361	$	3,309	$	52
Contract liabilities:
Deferred revenue	$	31	$	—	$	31

9

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Accounts receivable, unbilled in our TFE segment represents a contract asset for revenue that has been recognized in advance of billing the customer. For our system and certain upgrade sales, our TFE customers generally pay in three installments, with a portion of the system price billed upon receipt of an order, a portion of the price billed upon shipment, and the balance of the price due upon completion of installation and acceptance of the system at the customer’s factory. Accounts receivable, unbilled in our TFE segment generally represents the balance of the system price that is due upon completion of installation and acceptance, less the amount that has been deferred as revenue for the performance of the installation tasks. During the nine months ended September 26, 2020, contract assets in our TFE segment decreased by $200,000 primarily due to the subsequent invoicing of certain unbilled spare parts revenue at December 28, 2019.

Customer advances in our TFE segment generally represent a contract liability for amounts billed to the customer prior to transferring goods. The Company has elected to use the practical expedient to disregard the effect of the time value of money in a significant financing component when its payment terms are less than one year. These contract advances are liquidated when revenue is recognized. Deferred revenue in our TFE segment generally represents a contract liability for amounts billed to a customer for completed systems at the customer site that are undergoing installation and acceptance testing where transfer of control has not yet occurred, as Intevac does not yet have a demonstrated history of meeting the acceptance criteria upon the customer’s receipt of product. During the nine months ended September 26, 2020, we recognized revenue in our TFE segment of $4.0 million and $119,000 that was included in customer advances and deferred revenue, respectively, at the beginning of the period.

Accounts receivable, unbilled in our Photonics segment represents a contract asset for revenue that has been recognized in advance of billing the customer, which is common for contracts in the defense industry. In our Photonics segment, amounts are billed as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals (e.g., monthly) or upon achievement of contractual milestones. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. Our contracts with the U.S. government may also contain retainage provisions. Retainage represents a contract asset for the portion of the contract price earned by us for work performed but held for payment by the U.S. government as a form of security until satisfactory completion of the contract. The retainage is billable upon completion of the contract performance and approval of final indirect expense rates by the government. During the nine months ended September 26, 2020, contract assets in our Photonics segment increased by $52,000 primarily due to the accrual of revenue for incurred costs under FFP and CPFF contracts.

Deferred revenue in our Photonics segment generally represents a contract liability for amounts billed to the customer upon achievement of contractual milestones. These amounts are liquidated when revenue is recognized.

On September 26, 2020, we had $63.3 million of remaining performance obligations, which we also refer to as backlog. Backlog at September 26, 2020 consisted of $18.1 million of TFE backlog and $45.2 million of Photonics backlog. We expect to recognize approximately 42% of our remaining performance obligations as revenue in 2020, 30% in 2021, 18% in 2022, 9% in 2023 and 1% in 2024 and thereafter.

3. Inventories

Inventories are stated at the lower of average cost or net realizable value and consist of the following:

	September 26, 2020		December 28, 2019
	(In thousands)
Raw materials	$	11,166	$	15,286
Work-in-progress		5,732		4,748
Finished goods		6,740		4,873
	$	23,638	$	24,907

Net inventories at September 26, 2020 and December 28, 2019 included one VERTEX SPECTRA system for DCP under evaluation in a customer’s factory and one MATRIX PVD system for advance semiconductor packaging under evaluation in a customer’s factory. Net inventories at September 26, 2020 also included one VERTEX SPECTRA system for DCP at Intevac’s factory.

10

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

4. Equity-Based Compensation

At September 26, 2020, Intevac had equity-based awards outstanding under the 2020 Equity Incentive Plan, the 2012 Equity Incentive Plan and the 2004 Equity Incentive Plan (together, the “Plans”) and the 2003 Employee Stock Purchase Plan (the “ESPP”). Intevac’s stockholders approved all of these plans. The Plans permit the grant of incentive or non-statutory stock options, performance-based stock options (“PSOs”), restricted stock, stock appreciation rights, restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and performance shares.

The ESPP provides that eligible employees may purchase Intevac’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market value at the entry date of the applicable offering period or at the end of each applicable purchase interval. Offering periods are generally two years in length, and consist of a series of six-month purchase intervals. Eligible employees may join the ESPP at the beginning of any six-month purchase interval. Under the terms of the ESPP, employees can choose to have up to 50% of their base earnings withheld to purchase Intevac common stock (not to exceed $25,000 per year).

Equity-based Compensation Expense

The effect of recording equity-based compensation for the three and nine months ended September 26, 2020 and September 28, 2019 was as follows:

	Three Months Ended				Nine Months Ended
	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands)
Equity-based compensation by type of award:
Stock options	$	47	$	213	$	411	$	610
RSUs		495		375		1,311		1,018
ESPP awards		316		163		464		632
Total equity-based compensation	$	858	$	751	$	2,186	$	2,260

Stock Options and ESPP

The fair value of stock options and ESPP awards is estimated at the grant date using the Black-Scholes option valuation model. The determination of fair value of stock options and ESPP awards on the date of grant using an option-pricing model is affected by Intevac’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards and actual employee stock option exercise behavior. Intevac accounts for forfeitures as they occur, rather than estimating expected forfeitures. Option activity as of September 26, 2020 and changes during the nine months ended September 26, 2020 were as follows:

	Shares			Weighted-Average Exercise Price
Options outstanding at December 28, 2019		2,096,610		$	6.63
Options granted		6,000		$	4.88
Options cancelled and forfeited		(193,461	)	$	6.68
Options exercised		(61,722	)	$	4.77
Options outstanding at September 26, 2020		1,847,427		$	6.68
Options exercisable at September 26, 2020		1,395,582		$	6.80

Intevac issued 392,088 shares of common stock under the ESPP during the nine months ended September 26, 2020.

11

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Stock Options:
Weighted-average fair value of grants per share	$	—		$	1.84		$	1.82		$	2.05
Expected volatility		—			43.87	%		46.04	%		43.22	%
Risk-free interest rate		—			1.57	%		0.44	%		1.86	%
Expected term of options (in years)		—			4.32			4.39			4.56
Dividend yield		—			None			None			None
	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Stock Purchase Rights:
Weighted-average fair value of grants per share	$	2.20		$	1.45		$	2.20		$	1.73
Expected volatility		51.72	%		38.27	%		51.49	%		45.81	%
Risk-free interest rate		0.12	%		1.85	%		0.14	%		2.28	%
Expected term of purchase rights (in years)		1.26			0.75			1.24			0.91
Dividend yield		None			None			None			None

The computation of the expected volatility assumptions used in the Black-Scholes calculations for new stock option grants and ESPP purchase rights is based on the historical volatility of Intevac’s stock price, measured over a period equal to the expected term of the stock option grant or purchase right. The risk-free interest rate is based on the yield available on U.S. Treasury Strips with an equivalent remaining term. The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the equity-based awards and vesting schedules. The expected term of purchase rights represents the period of time remaining in the current offering period. The dividend yield assumption is based on Intevac’s history of not paying dividends and the assumption of not paying dividends in the future.

Performance-based stock options (“PSOs”) vest upon the achievement of certain market conditions (our stock performance) during a set performance period (typically 4 years) subject to the grantee’s continued service with Intevac through the date the applicable market condition is achieved. The fair value is based on the values calculated using a Monte Carlo simulation model on the grant date. Compensation cost is not adjusted in future periods for subsequent changes in the expected outcome of market related conditions. The compensation expense is recognized over the derived service period. We granted 37,500 of such stock options to the Chief Executive Officer in the three months ended June 29, 2019. These PSOs have a derived service period of 1.1 years.

Intevac estimated the weighted-average fair value of PSOs using the following weighted-average assumptions:

	Nine Months Ended September 28, 2019
Weighted-average fair value of grants per share	$	1.75
Expected volatility		43.43	%
Risk free interest rate		1.96	%
Expected term (in years)		4.60
Dividend yield		None

12

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

RSUs

RSU activity as of September 26, 2020 and changes during the nine months ended September 26, 2020 were as follows:

	Shares			Weighted-Average Grant Date Fair Value
Non-vested RSUs at December 28, 2019		553,355		$	6.15
Granted		658,090		$	4.85
Vested		(221,483	)	$	6.51
Cancelled and forfeited		(35,815	)	$	6.05
Non-vested RSUs at September 26, 2020		954,147		$	5.17

Time-based RSUs are converted into shares of Intevac common stock upon vesting on a one-for-one basis. Time-based RSUs typically are scheduled to vest over four years. Vesting of time-based RSUs is subject to the grantee’s continued service with Intevac. The compensation expense related to these awards is determined using the fair market value of Intevac common stock on the date of the grant, and the compensation expense is recognized over the vesting period.

In May 2020, we granted 109,465 performance-based restricted stock units (“PRSUs”) to members of our senior management. The PRSUs were issued collectively in four separate tranches with individual one-year performance periods beginning in May 2020, 2021, 2022 and 2023, respectively. Vesting of the PRSUs is based on the performance of our common stock relative to the performance of a peer group. The fair value of each PRSU award was estimated on the date of grant using a Monte Carlo simulation. PRSU activity is included in the above RSU tables. At the end of each performance measurement period, the Compensation Committee will determine the achievement against the performance objectives. Any earned PRSU awards will vest 100% after the end of the applicable performance measurement period.

Intevac estimated the weighted-average fair value of PRSUs using the following weighted-average assumptions:

	Nine Months Ended
	September 26, 2020
Weighted-average fair value of grants per share	$	3.16
Expected volatility		46.7	%
Risk-free interest rate		0.25	%
Dividend yield		None

5. Purchased Intangible Assets

Details of finite-lived intangible assets by segment as of September 26, 2020 are as follows.

	September 26, 2020
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
TFE	$	7,172	$	(7,172	)	$	—
Photonics		1,215		(1,211	)		4
	$	8,387	$	(8,383	)	$	4

Total amortization expense of finite-lived intangibles for the three and nine months ended September 26, 2020 was $11,000 and $270,000, respectively. On the condensed consolidated balance sheets, purchased intangible assets is included in deferred income taxes and other long-term assets. As of September 26, 2020, future amortization expense of $4,000 is expected to be recorded in 2020.

13

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

6. Acquisition-Related Contingent Consideration

In connection with the acquisition of Solar Implant Technologies, Inc. (“SIT”), Intevac agreed to pay to the selling shareholders in cash a revenue earnout on Intevac’s net revenues from commercial sales of certain products over a specified period up to an aggregate of $9.0 million. The earnout period terminated on June 30, 2019. There is no remaining contingent consideration obligation associated with the earnout agreement at September 26, 2020. The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the nine months ended September 28, 2019 (in thousands):

	Nine Months Ended
	September 28, 2019
Opening balance	$	223
Changes in fair value		7
Cash payments made		(230	)
Closing balance	$	—

7. Warranty

Intevac provides for the estimated cost of warranty when revenue is recognized. Intevac’s warranty is subject to contract terms and, for its HDD manufacturing, DCP manufacturing and solar cell manufacturing systems, the warranty typically ranges between 12 and 24 months from customer acceptance. During this warranty period any defective non-consumable parts are replaced and installed at no charge to the customer. Intevac uses estimated repair or replacement costs along with its historical warranty experience to determine its warranty obligation. The provision for the estimated future costs of warranty is based upon historical cost and product performance experience. Intevac exercises judgment in determining the underlying estimates.

On the condensed consolidated balance sheets, the short-term portion of the warranty provision is included in other accrued liabilities, while the long-term portion is included in other long-term liabilities. The expense associated with product warranties issued or adjusted is included in cost of net revenues on the condensed consolidated statements of operations.

The following table displays the activity in the warranty provision account for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
Opening balance	$	662		$	948		$	1,022		$	997
Expenditures incurred under warranties		(89	)		(167	)		(398	)		(592	)
Accruals for product warranties issued during the reporting period		39			427			198			829
Adjustments to previously existing warranty accruals		(57	)		(72	)		(267	)		(98	)
Closing balance	$	555		$	1,136		$	555		$	1,136

The following table displays the balance sheet classification of the warranty provision account at September 26, 2020 and at December 28, 2019:

	September 26,		December 28,
	2020		2019
	(In thousands)
Other accrued liabilities	$	425	$	846
Other long-term liabilities		130		176
Total warranty provision	$	555	$	1,022

14

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

8. Guarantees

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, Intevac has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at Intevac’s request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The maximum potential amount of future payments Intevac could be required to make under these indemnification obligations is unlimited; however, Intevac has a director and officer insurance policy that mitigates Intevac’s exposure and enables Intevac to recover a portion of any future amounts paid. As a result of Intevac’s insurance policy coverage, Intevac believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in Intevac’s industry, many of Intevac’s contracts provide remedies to certain third parties such as defense, settlement, or payment of judgments for intellectual property claims related to the use of its products. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.

Letters of Credit

As of September 26, 2020, we had letters of credit and bank guarantees outstanding totaling $787,000, including the standby letter of credit outstanding under the Santa Clara, California facility lease and various other guarantees with our bank. These letters of credit and bank guarantees are collateralized by $787,000 of restricted cash.

15

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

9. Cash, Cash Equivalents and Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

	September 26, 2020
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	23,829	$	—	$	—	$	23,829
Money market funds		3,416		—		—		3,416
Total cash and cash equivalents	$	27,245	$	—	$	—	$	27,245
Short-term investments:
Certificates of deposit	$	7,450	$	7	$	—	$	7,457
Commercial paper		499		1		—		500
Corporate bonds and medium-term notes		3,842		27		—		3,869
U.S. treasury and agency securities		6,481		35		—		6,516
Total short-term investments	$	18,272	$	70	$	—	$	18,342
Long-term investments:
Certificates of deposit	$	500	$	—	$	—	$	500
Corporate bonds and medium-term notes		2,572		2		—		2,574
Total long-term investments	$	3,072	$	2	$	—	$	3,074
Total cash, cash equivalents, and investments	$	48,589	$	72	$	—	$	48,661

	December 28, 2019
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	16,512	$	—	$	—	$	16,512
Money market funds		3,255		—		—		3,255
Total cash and cash equivalents	$	19,767	$	—	$	—	$	19,767
Short-term investments:
Certificates of deposit	$	3,000	$	1	$	—	$	3,001
Commercial paper		1,891		2		—		1,893
Corporate bonds and medium-term notes		6,383		25		—		6,408
U.S. treasury and agency securities		5,417		1		—		5,418
Total short-term investments	$	16,691	$	29	$	—	$	16,720
Long-term investments:
Certificates of deposit	$	499	$	1	$	—	$	500
Corporate bonds and medium-term notes		2,530		12		—		2,542
U.S. treasury and agency securities		2,494		1		—		2,495
Total long-term investments	$	5,523	$	14	$	—	$	5,537
Total cash, cash equivalents, and investments	$	41,981	$	43	$	—	$	42,024

16

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

The contractual maturities of available-for-sale securities at September 26, 2020 are presented in the following table.

	September 26, 2020
	Amortized Cost		Fair Value
	(In thousands)
Due in one year or less	$	21,688	$	21,758
Due after one through two years		3,072		3,074
	$	24,760	$	24,832

All prices for the fixed maturity securities including U.S. Treasury and agency securities, certificates of deposit, commercial paper, corporate bonds and municipal bonds are received from independent pricing services utilized by Intevac’s outside investment manager. This investment manager performs a review of the pricing methodologies and inputs utilized by the independent pricing services for each asset type priced by the vendor. In addition, on at least an annual basis, the investment manager conducts due diligence visits and interviews with each pricing vendor to verify the inputs utilized for each asset class. The due diligence visits include a review of the procedures performed by each vendor to ensure that pricing evaluations are representative of the price that would be received for a security in an orderly sale. Any pricing where the input is based solely on a broker price is deemed to be a Level 3 price. Intevac uses the pricing data obtained from its outside investment manager as the primary input to make its assessments and determinations as to the ultimate valuation of the above-mentioned securities and has not made, during the periods presented, any material adjustments to such inputs.

The following table represents the fair value hierarchy of Intevac’s available-for-sale securities measured at fair value on a recurring basis as of September 26, 2020.

	Fair Value Measurements at September 26, 2020
	Total		Level 1		Level 2
	(In thousands)
Recurring fair value measurements:
Available-for-sale securities
Money market funds	$	3,416	$	3,416	$	—
U.S. treasury and agency securities		6,516		6,516		—
Certificates of deposit		7,957		—		7,957
Commercial paper		500		—		500
Corporate bonds and medium-term notes		6,443		—		6,443
Total recurring fair value measurements	$	24,832	$	9,932	$	14,900

17

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

10. Derivative Instruments

The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. These derivatives are carried at fair value with changes recorded in interest income and other income (expense), net in the condensed consolidated statements of operations. Changes in the fair value of these derivatives are largely offset by re-measurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. The derivatives have original maturities of approximately 30 days.

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of September 26, 2020 and December 28, 2019:

	Notional Amounts				Derivative Liabilities
Derivative Instrument	September 26 2020		December 28, 2019		September 26, 2020				December 28, 2019
					Balance Sheet Line		Fair Value		Balance Sheet Line		Fair Value
	(In thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	871	$	1,035		(a)	$	5		(a)	$	4
Total Hedges	$	871	$	1,035			$	5			$	4

(a) Other accrued liabilities

11. Equity

Condensed Consolidated Statement of Changes in Equity

The changes in stockholders’ equity by component for the three and nine months ended September 26, 2020 and September 28, 2019, are as follows (in thousands):

	Three months ended September 26, 2020
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at June 27, 2020	$	190,290		$	(29,551	)	$	402	$	(63,486	)	$	97,655
Common stock issued under employee plans		871			—			—		—			871
Shares withheld for net share settlement of RSUs		(19	)		—			—		—			(19	)
Equity-based compensation expense		858			—			—		—			858
Net loss		—			—			—		(357	)		(357	)
Other comprehensive income		—			—			100		—			100
Balance at September 26, 2020	$	192,000		$	(29,551	)	$	502	$	(63,843	)	$	99,108

18

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

	Nine months ended September 26, 2020
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at December 28, 2019	$	188,313		$	(29,158	)	$	424	$	(63,786	)	$	95,793
Common stock issued under employee plans		1,865			—			—		—			1,865
Shares withheld for net share settlement of RSUs		(364	)		—			—		—			(364	)
Equity-based compensation expense		2,186			—			—		—			2,186
Net loss		—			—			—		(57	)		(57	)
Other comprehensive income		—			—			78		—			78
Common stock repurchases		—			(393	)		—		—			(393	)
Balance at September 26, 2020	$	192,000		$	(29,551	)	$	502	$	(63,843	)	$	99,108

	Three months ended September 28, 2019
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at June 29, 2019	$	185,489		$	(29,089	)	$	455		$	(68,508	)	$	88,347
Common stock issued under employee plans		749			—			—			—			749
Shares withheld for net share settlement of RSUs		(28	)		—			—			—			(28	)
Equity-based compensation expense		751			—			—			—			751
Net loss		—			—			—			(480	)		(480	)
Other comprehensive loss		—			—			(84	)		—			(84	)
Common stock repurchases		—			(69	)		—			—			(69	)
Balance at September 28, 2019	$	186,961		$	(29,158	)	$	371		$	(68,988	)	$	89,186

	Nine months ended September 28, 2019
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at December 29, 2018	$	183,227		$	(29,047	)	$	378		$	(64,934	)	$	89,624
Common stock issued under employee plans		1,770			—			—			—			1,770
Shares withheld for net share settlement of RSUs		(296	)		—			—			—			(296	)
Equity-based compensation expense		2,260			—			—			—			2,260
Net loss		—			—			—			(4,054	)		(4,054	)
Other comprehensive loss		—			—			(7	)		—			(7	)
Common stock repurchases		—			(111	)		—			—			(111	)
Balance at September 28, 2019	$	186,961		$	(29,158	)	$	371		$	(68,988	)	$	89,186

19

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Accumulated Other Comprehensive Income

The changes in accumulated other comprehensive income by component for the three and nine months ended September 26, 2020 and September 28, 2019, are as follows.

	Three Months Ended									Nine Months Ended
	September 26, 2020
	Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total			Foreign currency			Unrealized holding gains on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	306		$	96		$	402		$	381		$	43		$	424
Other comprehensive income (loss) before reclassification		124			(24	)		100			49			29			78
Amounts reclassified from other comprehensive income (loss)		—			—			—			—			—			—
Net current-period other comprehensive income		124			(24	)		100			49			29			78
Ending balance	$	430		$	72		$	502		$	430		$	72		$	502
	Three Months Ended									Nine Months Ended
	September 28, 2019
	Foreign currency			Unrealized holding gains on available-for-sale investments			Total			Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	405		$	50		$	455		$	405		$	(27	)	$	378
Other comprehensive income (loss) before reclassification		(87	)		3			(84	)		(87	)		80			(7	)
Amounts reclassified from other comprehensive income (loss)		—			—			—			—			—			—
Net current-period other comprehensive loss		(87	)		3			(84	)		(87	)		80			(7	)
Ending balance	$	318		$	53		$	371		$	318		$	53		$	371

Stock Repurchase Program

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. On August 15, 2018, Intevac’s Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of up to $40.0 million. At September 26, 2020, $10.4 million remains available for future stock repurchases under the repurchase program.

The following table summarizes Intevac’s stock repurchases:

	Three Months Ended				Nine Months Ended
	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands, except per share amounts)
Shares of common stock repurchased		—		15		98		24
Cost of stock repurchased	$	—	$	69	$	393	$	111
Average price paid per share	$	—	$	4.65	$	3.97	$	4.67

20

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Intevac records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If Intevac reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against the accumulated deficit.

12. Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands, except per share amounts)
Net loss	$	(357	)	$	(480	)	$	(57	)	$	(4,054	)
Weighted-average shares – basic		23,771			23,130			23,605			22,992
Effect of dilutive potential common shares		—			—			—			—
Weighted-average shares – diluted		23,771			23,130			23,605			22,992
Net loss per share – basic	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)
Net loss per share – diluted	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)

As the Company is in a net loss position, all of the Company’s equity instruments are considered antidilutive.

13. Segment Reporting

Intevac’s two reportable segments are TFE and Photonics. Intevac’s chief operating decision-maker has been identified as the President and CEO, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Segment information is presented based upon Intevac’s management organization structure as of September 26, 2020 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to the reportable segments disclosed.

Each reportable segment is separately managed and has separate financial results that are reviewed by Intevac’s chief operating decision-maker. Each reportable segment contains closely related products that are unique to the particular segment. Segment operating profit is determined based upon internal performance measures used by the chief operating decision-maker.

Intevac derives the segment results from its internal management reporting system. The accounting policies Intevac uses to derive reportable segment results are substantially the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics, including orders, net revenues and operating income. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. Intevac manages certain operating expenses separately at the corporate level. Intevac allocates certain of these corporate expenses to the segments in an amount equal to 3% of net revenues. Segment operating income excludes interest income/expense and other financial charges and income taxes according to how a particular reportable segment’s management is measured. Management does not consider impairment charges, gains and losses on divestitures and sales of intellectual property, or unallocated costs in measuring the performance of the reportable segments.

The TFE segment designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the hard drive, solar cell and DCP industries, as well as other adjacent thin-film markets.

The Photonics segment develops compact, cost-effective, high-sensitivity digital-optical products for the capture and display of low-light images. Intevac provides sensors, cameras and systems for government applications such as night vision.

21

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Information for each reportable segment for the three and nine months ended September 26, 2020 and September 28, 2019 is as follows:

Net Revenues

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
TFE	$	9,367		$	17,116		$	33,925		$	49,325
Photonics		12,198			9,183			35,323			24,116
Total segment net revenues	$	21,565		$	26,299		$	69,248		$	73,441
Operating Income (Loss)
	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
TFE	$	(1,661	)	$	(1,542	)	$	(4,366	)	$	(3,434	)
Photonics		3,032			2,268			9,480			3,114
Total segment operating income (loss)		1,371			726			5,114			(320	)
Unallocated costs		(1,519	)		(1,159	)		(4,258	)		(3,038	)
Income (loss) from operations		(148	)		(433	)		856			(3,358	)
Interest income and other income (expense), net		8			126			212			448
Income (loss) before provision for income taxes	$	(140	)	$	(307	)	$	1,068		$	(2,910	)

Total assets for each reportable segment as of September 26, 2020 and December 28, 2019 are as follows:

Assets

	September 26, 2020		December 28, 2019
	(In thousands)
TFE	$	45,819	$	51,153
Photonics		19,049		22,071
Total segment assets		64,868		73,224
Cash, cash equivalents and investments		48,661		42,024
Restricted cash		787		787
Deferred income taxes		5,736		6,252
Other current assets		1,145		752
Common property, plant and equipment		1,461		1,307
Common operating lease right-of-use assets		1,711		1,898
Other assets		—		78
Consolidated total assets	$	124,369	$	126,322

22

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

14. Income Taxes

Intevac recorded income tax provisions of $217,000 and $1.1 million for the three and nine months ended September 26, 2020, respectively, and $173,000 and $1.1 million for the three and nine months ended September 28, 2019, respectively. The income tax provisions for these three and nine month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. For the three and nine month periods ended September 26, 2020 Intevac recorded income tax provisions on earnings of its international subsidiaries of $111,000 and $659,000, respectively, and recorded $98,000 and $471,000, respectively, for withholding taxes on royalties paid into the United States from Intevac’s Singapore subsidiary as discrete items. For the three and nine month periods ended September 28, 2019, Intevac recorded income tax provisions on earnings of its international subsidiaries of $48,000 and $611,000, respectively, and recorded $130,000 and $534,000, respectively, for withholding taxes on royalties paid into the United States from Intevac’s Singapore subsidiary as discrete items. For all periods presented Intevac utilized net operating loss carry-forwards to offset the impact of global intangible low-taxed income (“GILTI”). Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

The Inland Revenue Authority of Singapore (“IRAS”) conducted a review of the fiscal 2009 through 2010 tax returns of the Company’s wholly-owned subsidiary, Intevac Asia Pte. Ltd. IRAS challenged the Company’s tax position with respect to certain deductions. The Company paid all contested taxes and the related interest to have the right to defend its position under Singapore tax law. In October 2020, the Company received an unfavorable decision on its appeal to the Singapore High Court. Management is considering a further appeal to the Court of Appeal, which must be made within thirty days of the High Court decision. As of September 26, 2020, the $915,000 contested tax deposit reported on its balance sheet was fully reserved.

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. The CARES Act includes several significant provisions for corporations, including the usage of net operating losses and payroll benefits. Several foreign (non-U.S.) jurisdictions in which we operate have taken similar economic stimulus measures. The Company evaluated the provisions of the CARES Act and other non-U.S. economic measures and determined the impact on our financial position at September 26, 2020 and on the results of operations and cash flows for the three and nine months then ended as well as anticipated future benefits for the remainder of fiscal 2020 to be as follows.

Under the CARES Act, we have elected to defer payment, on an interest-free basis, of the employer portion of social security payroll taxes incurred from March 27, 2020 to December 31, 2020. One-half of such deferral amount will become due on each of December 31, 2021 and December 31, 2022. We elected to utilize this deferral program to delay payment of approximately $763,000 of the employer portion of payroll taxes estimated to be incurred between March 27, 2020 and December 31, 2020. The deferred payroll tax liability of $547,000 at September 26, 2020 is included in other long-term liabilities on the condensed consolidated balance sheets. The Company will also utilize the employee retention tax credit under the CARES Act for certain qualifying employee salary and wage expenditures. Tax benefits under the employee retention tax credit are not expected to be significant. Additionally, the CARES Act accelerates the timing of the refund for alternative minimum tax (“AMT”) credits. The entire balance of the income tax refund receivable of $157,000 was received in July 2020.

In Singapore, Intevac receives government assistance under the Job Support Scheme (“JSS”). The purpose of the JSS is to provide wage support to employers to help them retain their local employees. Under the JSS, Intevac expects to receive approximately $554,000 in JSS grants in fiscal 2020. During the quarter ended September 26, 2020, the Company received $124,000 in JSS grants, of which $72,000 is reported as a reduction of cost of net revenues, $20,000 is reported as a reduction of R&D expenses and $32,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations. During the nine months ended September 26, 2020, the Company received $434,000 in JSS grants, of which $252,000 is reported as a reduction of cost of net revenues, $68,000 is reported as a reduction of R&D expenses and $114,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations.

23

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

15. Restructuring Charges

During the third quarter of fiscal 2020, Intevac substantially completed implementation of the 2020 cost reduction plan (the “Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 1.0 percent. The cost of implementing the Cost Reduction Plan was reported under cost of net revenues and operating expenses in the condensed consolidated statements of operations. Substantially all cash outlays in connection with the Cost Reduction Plan occurred in the third quarter of fiscal 2020. Implementation of the Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $864,000 on an annual basis.

The changes in restructuring reserves, which resulted from cash-based severance payments and other employee-related costs, associated with the Cost Reduction Plan for the three and nine months ended September 26, 2020 were as follows.

	Three and Nine Months Ended September 26, 2020
	(In thousands)
Beginning balance	$	—
Provision for restructuring reserves		103
Cash payments made		(103	)
Ending balance	$	—

16. Contingencies

From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.

24

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements, which involve risks and uncertainties. Words such as “believes,” “expects,” “anticipates” and the like indicate forward-looking statements. These forward-looking statements include comments related to Intevac’s expected shipments, revenue recognition, product costs, gross margin, operating expenses, interest income, income taxes, cash balances and financial results in 2020 and beyond; projected customer requirements for Intevac’s new and existing products, and when, and if, Intevac’s customers will place orders for these products; Intevac’s ability to proliferate its Photonics technology into major military programs and to develop and introduce commercial imaging products; the timing of delivery and/or acceptance of the systems and products that comprise Intevac’s backlog for revenue and the Company’s ability to achieve cost savings. Intevac’s actual results may differ materially from the results discussed in the forward-looking statements for a variety of reasons, including those set forth under “Risk Factors” and in other documents we file from time to time with the Securities and Exchange Commission, including our Annual Report on Form 10-K filed on February 12, 2020, and our periodic reports on Form 10-Q and current reports on Form 8-K.

Intevac’s trademarks include the following: “200 Lean®,” “DiamondClad®,” “DIAMOND DOG®,” “EBAPS®,” “ENERGi®,” “LIVAR®,” “INTEVAC LSMA®,” “INTEVAC MATRIX®,” “MicroVista®,” “NightVista®,” “oDLC®,” “INTEVAC VERTEX®,” “VERTEX Marathon®,” and “VERTEX SPECTRA®.”

Overview

Intevac is a provider of vacuum deposition equipment for a wide variety of thin-film applications, and a leading provider of digital night-vision technologies and products to the defense industry. The Company leverages its core capabilities in high-volume manufacturing of small substrates to provide process manufacturing equipment solutions to the hard disk drive (“HDD”), display cover panel (“DCP”), and photovoltaic (“PV”) solar cell industries. Intevac also provides sensors, cameras and systems for government applications such as night vision. Intevac’s customers include manufacturers of hard disk media, DCPs and solar cells as well as the U.S. government and its agencies, allies and contractors. Intevac reports two segments: Thin-film Equipment (“TFE”) and Photonics.

Product development and manufacturing activities occur in North America and Asia. Intevac has field offices in Asia to support its TFE customers. Intevac’s products are highly technical and are sold primarily through Intevac’s direct sales force. Intevac also sells its products through distributors in Japan and China.

Intevac’s results are driven by a number of factors including success in its equipment growth initiatives in the DCP and solar markets and by worldwide demand for HDDs. Demand for HDDs depends on the growth in digital data creation and storage, the rate of areal density improvements, and the end-user demand for PCs, enterprise data storage, nearline “cloud” applications, video players and video game consoles that include such drives. Intevac continues to execute its strategy of equipment diversification into new markets by introducing new products, such as for a thin-film physical vapor deposition (“PVD”) application for protective coating for DCP manufacturing and a thin-film PVD application for PV solar cell manufacturing. Intevac believes that expansion into these markets will result in incremental equipment revenues for Intevac and decrease Intevac’s dependence on the HDD industry. Intevac’s equipment business is subject to cyclical industry conditions, as demand for manufacturing equipment and services can change depending on supply and demand for HDDs, cell phones and PV cells, as well as other factors such as global economic conditions and technological advances in fabrication processes.

The following table presents certain significant measurements for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three months ended									Nine months ended
	September 26, 2020			September 28, 2019			Change over prior period			September 26, 2020			September 28, 2019			Change over prior period
	(In thousands, except percentages and per share amounts)
Net revenues	$	21,565		$	26,299		$	(4,734	)	$	69,248		$	73,441		$	(4,193	)
Gross profit	$	9,300		$	8,778		$	522		$	28,876		$	24,375		$	4,501
Gross margin percent		43.1	%		33.4	%		9.7 points			41.7	%		33.2	%		8.5 points
Income (loss) from operations	$	(148	)	$	(433	)	$	285		$	856		$	(3,358	)	$	4,214
Net loss	$	(357	)	$	(480	)	$	123		$	(57	)	$	(4,054	)	$	3,997
Net loss per diluted share	$	(0.02	)	$	(0.02	)	$	0.00		$	(0.00	)	$	(0.18	)	$	0.18

25

Net revenues for the third quarter of fiscal 2020 decreased compared to the same period in the prior year primarily due to lower equipment sales to PV manufacturers, offset in part by higher equipment sales to HDD manufacturers, higher Photonics product sales and higher Photonics contract research and development (“R&D”). TFE did not recognize revenue on any systems in the third quarter of fiscal 2020. TFE recognized revenue on five ENERGi solar ion implant systems in the third quarter of fiscal 2019. During the third quarter of fiscal 2020, the Company received $124,000 in government assistance related to COVID-19 from the government of Singapore of which $72,000 was reported as a reduction of cost of net revenues, $20,000 was reported as a reduction of R&D expenses and $32,000 was reported as a reduction of selling, general and administrative expenses. The Company reported a smaller net loss for the third quarter of fiscal 2020 compared to the third quarter of 2019 due to higher gross profit, offset in part by lower revenues and higher spending on R&D and selling, general and administrative expenses.

Net revenues for the first nine months of fiscal 2020 decreased compared to the same period in the prior year primarily due to lower equipment sales to PV manufacturers and lower equipment sales to HDD manufacturers, offset in part by higher Photonics product sales and higher Photonics contract R&D. TFE recognized revenue in the first nine months of fiscal 2020 on two 200 Lean HDD systems compared to two 200 Lean HDD systems and nine ENERGi solar ion implant systems in the first nine months of fiscal 2019. During the nine months of fiscal 2020, the Company received $434,000 in government assistance related to COVID-19 from the government of Singapore of which $252,000 was reported as a reduction of cost of net revenues, $68,000 was reported as a reduction of R&D expenses and $114,000 was reported as a reduction of selling, general and administrative expenses. The Company reported a smaller net loss for first nine months of fiscal 2020 compared to first nine months of fiscal 2019 due to higher gross profit and lower spending on R&D, offset in part by lower revenues and higher selling, general and administrative expenses.

Intevac expects that HDD equipment sales for 2020 will be down from 2019 levels as an HDD manufacturer took delivery of the two remaining 200 Lean HDD systems in backlog. In 2020, Intevac expects lower sales of new TFE products as we expect delays in orders and revenue recognition for both our VERTEX system and solar ion implant ENERGi system. We expect these delays in orders and revenue recognition for our TFE products will continue into 2021. Both evaluation systems at customer factories are expected to be recognized as revenue in 2021. In 2020, we expect increased product revenue in Photonics as we continue to deliver product shipments of the Apache camera and the night-vision camera modules for the F35 Joint Strike Fighter (“JSF”) program. In 2020, we expect increased contract R&D revenue as development work continues on the multi-year IVAS contract award for the development and production of digital night-vision cameras to support the U.S. Army’s IVAS program. For fiscal 2020, Intevac expects that Photonics profits will be higher than for fiscal 2019 as Photonics results will reflect higher revenue levels.

The Impact of COVID-19

We are unable to accurately predict the possible future effect of the COVID-19 outbreak on the Company, which could be material to our 2020 results. Our customers may delay or cancel orders due to reduced demand, supply chain disruptions and/or travel restrictions and border closures. As the economic impact of the COVID-19 pandemic becomes more clear as the year progresses, we could see significant changes to our operations. Our factories in California and Singapore remain open as both TFE and Photonics businesses are within the critical infrastructure sectors. We have experienced pandemic-related delays in our TFE evaluation and development work. In response to COVID-19, we have implemented initiatives to safeguard our employees in this time of crisis. We have implemented work-from-home protocols and all employees that can do so are working remotely and will continue to do so until restrictions are lifted by the applicable authorities in the United States, Singapore and China. The Company has been providing a bi-weekly update to its Board of Directors highlighting the impacts of COVID-19 on its employees, business and financial condition. The following discussion highlights how we are responding and the expected impacts of COVID-19 on our business.

Essential Business

The Company’s priorities during the COVID-19 pandemic have been to protect the health and safety of employees while keeping its manufacturing facilities open due to the essential nature of our products. Our factories in California and Singapore remain open as both TFE and Photonics businesses are within critical infrastructure sectors that are exempt from government-mandated closures.

On March 16, 2020, multiple counties in the San Francisco Bay Area of California issued a “shelter-in-place” order (the “State Order”) requiring businesses to temporarily cease operations, effective March 17, 2020. The State Order provides that Californians working within 16 identified critical infrastructure sectors may continue with their work because of the importance of these sectors to Californians’ health and well-being. Among the identified critical infrastructure sectors listed are Communications and Information Technology (“IT”) and the Defense Industrial Base (“DIB”). On March 20, 2020, Intevac received a communication from the Department of Defense stating that the DIB is identified as a Critical Infrastructure Sector by the Department of Homeland Security, and that the Essential Critical Infrastructure Workforce for the DIB includes workers who support the essential products and services required to meet national security commitments to the Federal Government and the U.S. Military.

26

Our factory in Singapore was given notice by the Singapore government to suspend all on-site activities on April 27, 2020. We appealed this notice and were provided an exemption on May 14, 2020. We were temporarily required to limit the number of employees on site at our Singapore factory, but these restrictions were lifted on June 2, 2020.

Employee Considerations

Our goal has been to support our employees during the present uncertainty while remaining focused on meeting the needs of our customers and business continuity. Early in the crisis, we provided employees with information about best practices to prevent the spread of COVID-19 and other viruses and illnesses. We instituted practices including symptom checks and non-contact monitoring of body temperatures of those on site twice daily; requiring social distancing and face coverings; streamlining onsite personnel to only those required for production; strongly encouraging and, where mandated, requiring remote work for all those who can work from home; and increasing hygiene through disinfecting facilities. In addition, we have limited in-person meetings and non-employee visits to our locations, reduced room occupancies and eliminated non-essential business travel. In the United States, the Company has educated employees on COVID-19-related benefits (including leave benefits) under the Families First Coronavirus Response Act (“FFCRA”) and the CARES Act.

To further protect the health and welfare of our employees, we have also required employees who potentially have been exposed to COVID-19 to self-quarantine for 14 days and have committed to paying these employees their normal wages during that quarantine period. To ease access to medical assistance, we are waiving co-payments for COVID-19 testing and telemedicine for those employees enrolled in our health insurance plans.

Business Continuity Team

We have robust pandemic and business continuity plans that include our business units and technology environments. When COVID-19 was declared a pandemic, we activated our business continuity plan (the “Continuity Plan”). As an element of the Continuity Plan, we activated our Business Continuity Team (“BCT”), a group of senior corporate managers, who directed a series of activities to address the health and safety of our workforce, assist employees, sustain business operations, coordinate communication and address our management concerning other ongoing pandemic activities. The BCT monitors guidelines published by the Centers for Disease Control and Prevention (“CDC”), the National Institutes of Health (“NIH”), the Occupational Safety and Health Administration (“OSHA”), the World Health Organization (“WHO”) and other state and local authorities, makes assessments of these guidelines and implements the appropriate protocols. The BCT established a COVID-19 Policy and continually updates this policy based on the latest guidance. All employees continuing to work on site were required to complete training on the Company’s COVID-19 policy and any employees returning to work at our facilities are provided additional training prior to returning to work. The BCT also updated and revised policies related to visitors and travel to include COVID-19-related health and safety measures related to the pandemic and updated the Continuity Plan to include a pandemic response appendix.

Productivity

There has been a modest decline in productivity for certain departments as our people adjust to this significant change in work environment. We currently believe our technology infrastructure is sufficient to maintain a remote-working environment for the vast majority of our workforce for the foreseeable future and that productivity should improve as our people adjust to this significant change in work environment. The productivity level and ability of our employees to continue working from home could change, however, as conditions surrounding COVID-19 evolve and infections increase, if there are interruptions in the internet infrastructure where our employees live or if internet service providers are otherwise adversely affected.

Community

We understand that the communities in which our employees live, work, and serve are also suffering distress as a result of COVID-19. Intevac is committed to help source supplies for local healthcare providers fighting COVID-19, and has donated all of its surplus N95 industrial masks and gloves to local hospitals and emergency responders.

Economic Relief

In Singapore, Intevac receives government assistance under the Job Support Scheme (“JSS”). The purpose of the JSS is to provide wage support to employers to help them retain their local employees. Under the JSS, Intevac expects to receive approximately $554,000 in JSS grants in fiscal 2020. During the three and nine months ended September 26, 2020, the Company received $124,000 and $434,000, respectively in JSS grants. As previously mentioned, under the CARES Act we have elected to defer the payment of the employer portion of payroll taxes and will receive tax benefits from the employee-retention-tax credit.

27

For the three and nine months ended September 26, 2020, the Company’s expenses included approximately $32,000 and $101,000 respectively due to costs related to actions taken in response to COVID-19.

Results of Operations

Net revenues

	Three months ended							Nine months ended
	September 26, 2020		September 28, 2019		Change over prior period			September 26, 2020		September 28, 2019		Change over prior period
	(In thousands)
TFE	$	9,367	$	17,116	$	(7,749	)	$	33,925	$	49,325	$	(15,400	)
Photonics:
Contract R&D		6,538		5,209		1,329			17,659		13,476		4,183
Products		5,660		3,974		1,686			17,664		10,640		7,024
		12,198		9,183		3,015			35,323		24,116		11,207
Total net revenues	$	21,565	$	26,299	$	(4,734	)	$	69,248	$	73,441	$	(4,193	)

TFE revenue for the three months ended September 26, 2020 decreased compared to the same period in the prior year as a result of lower sales of systems, offset in part by higher sales of technology upgrades, service and spare parts. TFE revenue for the three months ended September 26, 2020 did not include any systems. TFE revenue for the three months ended September 28, 2019 included five ENERGi solar ion implant systems. TFE revenue for the nine months ended September 26, 2020 decreased compared to the same period in the prior year as a result of lower sales of systems and technology upgrades, offset in part by higher sales of service and spare parts. TFE recognized revenue in the first nine months of fiscal 2020 on two 200 Lean HDD systems. TFE recognized revenue in the first nine months of fiscal 2019 on two 200 Lean HDD systems and nine ENERGi solar ion implant systems.

Photonics revenue for the three and nine months ended September 26, 2020 increased compared to the same periods in the prior year as a result of higher product sales revenues and higher contract R&D work.

Backlog

	September 26, 2020		December 28, 2019		September 28, 2019
	(In thousands)
TFE	$	18,092	$	21,391	$	39,310
Photonics		45,159		71,015		76,123
Total backlog	$	63,251	$	92,406	$	115,433

TFE backlog at September 26, 2020 did not include any systems. TFE backlog at December 28, 2019 included two 200 Lean HDD systems. TFE backlog at September 28, 2019 included four 200 Lean HDD systems.

Revenue by geographic region

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	1,764	$	12,079	$	13,843	$	478	$	9,050	$	9,528
Asia		7,536		—		7,536		16,638		—		16,638
Europe		67		119		186		—		133		133
Total net revenues	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299

28

	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	2,596	$	35,060	$	37,656	$	995	$	23,578	$	24,573
Asia		31,262		—		31,262		48,330		—		48,330
Europe		67		263		330		—		538		538
Total net revenues	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

International sales include products shipped to overseas operations of U.S. companies. The increase in sales to the U.S. region in the first nine months of fiscal 2020 versus the first nine months of fiscal 2019 reflected higher Photonics product sales and higher Photonics contract R&D work. The decrease in sales to the Asia region in the first nine months of fiscal 2020 versus the first nine months of fiscal 2019 reflected lower equipment sales to PV manufacturers and HDD manufacturers. Sales to the Asia region in the first nine months of fiscal 2020 included two 200 Lean HDD systems versus two 200 Lean HDD systems and nine ENERGi solar ion implant systems in the first nine months of fiscal 2019. Sales to the Europe region in the first nine months of fiscal 2020 and the first nine months of fiscal 2019 were not significant.

Gross profit

	Three months ended									Nine months ended
	September 26, 2020			September 28, 2019			Change over prior period			September 26, 2020			September 28, 2019			Change over prior period
	(In thousands, except percentages)
TFE gross profit	$	4,075		$	4,825		$	(750	)	$	13,622		$	15,958		$	(2,336	)
% of TFE net revenues		43.5	%		28.2	%					40.2	%		32.4	%
Photonics gross profit	$	5,225		$	3,953		$	1,272		$	15,254		$	8,417		$	6,837
% of Photonics net revenues		42.8	%		43.1	%					43.2	%		34.9	%
Total gross profit	$	9,300		$	8,778		$	522		$	28,876		$	24,375		$	4,501
% of net revenues		43.1	%		33.4	%					41.7	%		33.2	%

Cost of net revenues consists primarily of purchased materials and costs attributable to contract research and development, and also includes fabrication, assembly, test and installation labor and overhead, customer-specific engineering costs, warranty costs, royalties, provisions for inventory reserves and scrap.

TFE gross margin was 43.5% in the three months ended September 26, 2020 compared to 28.2% in the three months ended September 28, 2019 and was 40.2% in the nine months ended September 26, 2020 compared to 32.4% in the nine months ended September 28, 2019. Gross margin for the three and nine months ended September 28, 2019 reflected the sale of lower margin ENERGi solar ion implant systems. Gross margins in the TFE business will vary depending on a number of factors, including product mix, product cost, system configuration and pricing, factory utilization, and provisions for excess and obsolete inventory.

Photonics gross margin was 42.8% in the three months ended September 26, 2020 compared to 43.1% in the three months ended September 28, 2019 and was 43.2% in the nine months ended September 26, 2020 compared to 34.9% in the nine months ended September 28, 2019. Gross margin for the three months ended September 26, 2020 was flat versus the same period in the prior year. The improvement in gross margin for the nine months ended September 26, 2020 was due to higher revenue levels and improved margins on both products and contract R&D work. Gross margins in the Photonics business will vary depending on a number of factors, including sensor yield, product mix, product cost, pricing, factory utilization, provisions for warranty and inventory reserves.

29

Research and development

	Three months ended						Nine months ended
	September 26, 2020		September 28, 2019		Change over prior period		September 26, 2020		September 28, 2019		Change over prior period
	(In thousands)
Research and development expense	$	3,603	$	3,596	$	7	$	10,594	$	11,013	$	(419	)

Research and development spending in TFE during the three months ended September 26, 2020 decreased slightly compared to the same period in the prior year due to lower spending on DCP and HDD development, offset in part by higher spending on semiconductor Fan-out and PV development. Research and development spending in TFE during the nine months ended September 26, 2020 decreased compared to the same period in the prior year due to lower spending on HDD, DCP and PV development, offset in part by higher spending on semiconductor Fan-out development. TFE spending consisted primarily of DCP, semiconductor Fan-out, HDD and PV development. Research and development spending increased in Photonics during the three and nine months ended September 26, 2020, as compared to the same period in the prior year, primarily related to higher spending on the development of the next generation of our low light level CMOS camera. Research and development spending decreased in Photonics during the nine months ended September 26, 2020, as compared to the same period in the prior year, primarily related to lower spending on the development of the next generation of our low light level CMOS camera. Research and development expenses do not include costs of $3.9 million and $10.4 million for the three and nine months ended September 26, 2020 respectively, or $3.3 million and $9.3 million for the three and nine months ended September 28, 2019 respectively, which are related to customer-funded Photonics contract R&D programs and therefore included in cost of net revenues.

Selling, general and administrative

	Three months ended						Nine months ended
	September 26, 2020		September 28, 2019		Change over prior period		September 26, 2020		September 28, 2019		Change over prior period
	(In thousands)
Selling, general and administrative expense	$	5,845	$	5,615	$	230	$	17,426	$	16,720	$	706

Selling, general and administrative expense consists primarily of selling, marketing, customer support, financial and management costs. Selling, general and administrative expenses for the three months ended September 26, 2020 increased compared to the same period in the prior year primarily due to higher variable compensation expenses and incremental costs to launch our Diamond Dog e-commerce website. Selling, general and administrative expenses for the nine months ended September 26, 2020 increased compared to the same period in the prior year primarily due to higher variable compensation expenses and incremental e-commerce costs, offset in part due to lower spending to support a customer evaluation.

Cost reduction plan

During the third quarter of fiscal 2020, Intevac substantially completed implementation of the 2020 cost reduction plan (the “Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 1.0 percent. The total cost of implementing the Cost Reduction Plan was $103,000 of which $16,000 was reported under cost of net revenues and $87,000 was reported under operating expenses. Substantially all cash outlays in connection with the Cost Reduction Plan were completed in the third quarter of fiscal 2020. Implementation of the Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $864,000 on an annual basis.

Interest income and other income (expense), net

	Three months ended							Nine months ended
	September 26, 2020		September 28, 2019		Change over prior period			September 26, 2020		September 28, 2019		Change over prior period
	(In thousands)
Interest income and other income (expense), net	$	8	$	126	$	(118	)	$	212	$	448	$	(236	)

Interest income and other income (expense), net is comprised of interest income, foreign currency gains and losses, and other income and expense such as gains and losses on sales of fixed assets and earnout income from divestitures.

30

Interest income and other income (expense), net in the three months ended September 26, 2020 included $46,000 of interest income on investments and various other income of $3,000, offset in part by $41,000 of foreign currency losses. Interest income and other income (expense), net in the nine months ended September 26, 2020 included $247,000 of interest income on investments and various other income of $12,000, offset in part by $47,000 of foreign currency losses. Interest income and other income (expense), net in the three months ended September 28, 2019 included $143,000 of interest income on investments and various other income of $19,000, offset in part by $36,000 of foreign currency losses. Interest income and other income (expense), net in the nine months ended September 28, 2019 included $445,000 of interest income on investments, $20,000 of earnout income from a divestiture and various other income of $54,000, offset in part by $71,000 of foreign currency losses. The decrease in interest income in the three and nine months ended September 26, 2020 resulted from lower interest rates and lower invested balances compared to the same period in 2019.

Provision for income taxes

	Three months ended						Nine months ended
	September 26, 2020		September 28, 2019		Change over prior period		September 26, 2020		September 28, 2019		Change over prior period
	(In thousands)
Provision for income taxes	$	217	$	173	$	44	$	1,125	$	1,144	$	(19	)

Intevac recorded income tax provisions of $217,000 and $1.1 million for the three and nine months ended September 26, 2020, respectively, and $173,000 and $1.1 million for the three and nine months ended September 28, 2019, respectively. The income tax provisions for these three and nine month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. For the three and nine month periods ended September 26, 2020, Intevac recorded income tax provisions on earnings of its international subsidiaries of $111,000 and $659,000, respectively, and recorded $98,000 and $471,000, respectively, for withholding taxes on royalties paid into the United States from Intevac’s Singapore subsidiary as discrete items. For the three and nine month periods ended September 28, 2019, Intevac recorded income tax provisions on earnings of its international subsidiaries of $48,000 and $611,000 respectively, and recorded $130,000 and $534,000, respectively, for withholding taxes on royalties paid into the United States from Intevac’s Singapore subsidiary as discrete items. For all periods presented, Intevac utilized net operating loss carry-forwards to offset the impact of the global intangible low-taxed income (“GILTI”). Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

Liquidity and Capital Resources

At September 26, 2020, Intevac had $49.4 million in cash, cash equivalents, restricted cash and investments compared to $42.8 million at December 28, 2019. During the first nine months of fiscal 2020, cash, cash equivalents, restricted cash and investments increased by $6.6 million due primarily to cash provided by operating activities and cash received from the sale of Intevac common stock to Intevac’s employees through Intevac’s employee benefit plans, offset in part by purchases of fixed assets, cash used for repurchases of common stock and tax payments for net share settlement.

Cash, cash equivalents, restricted cash and investments consist of the following:

	September 26, 2020		December 28, 2019
	(In thousands)
Cash and cash equivalents	$	27,245	$	19,767
Restricted cash		787		787
Short-term investments		18,342		16,720
Long-term investments		3,074		5,537
Total cash, cash equivalents, restricted cash and investments	$	49,448	$	42,811

31

Operating activities generated cash of $7.8 million during the first nine months of fiscal 2020 and used cash of $1.1 million during the first nine months of 2019. Improved operating cash flow in the first nine months of fiscal 2020 was primarily a result of recognition of a smaller net loss and decreased investments in working capital during the first nine months of fiscal 2020.

Accounts receivable totaled $23.2 million at September 26, 2020 compared to $28.6 million at December 28, 2019. Net inventories totaled $23.6 million at September 26, 2020 compared to $24.9 million at December 28, 2019. Net inventories at September 26, 2020 and December 28, 2019 included one VERTEX SPECTRA system for DCP under evaluation in a customer’s factory and one MATRIX PVD system for advance semiconductor packaging under evaluation in a customer’s factory. Net inventories at September 26, 2020 also included one VERTEX SPECTRA system for DCP at Intevac’s factory. Accounts payable increased to $4.5 million at September 26, 2020 from $4.2 million at December 28, 2019 due to increased manufacturing activities. Accrued payroll and related liabilities was $6.5 million at both September 26, 2020 and December 28, 2019. Other accrued liabilities decreased to $2.3 million at September 26, 2020 compared to $3.6 million at December 28, 2019. Customer advances decreased from $4.0 million at December 28, 2019 to $1.1 million at September 26, 2020, primarily due the recognition of revenue offset in part by the recognition of new orders.

Investing activities used cash of $1.5 million during the first nine months of fiscal 2020. Proceeds from sales net of purchases of investments totaled $879,000. Capital expenditures for the nine months ended September 26, 2020 were $2.3 million.

Financing activities generated cash of $1.1 million in the first nine months of fiscal 2020. The sale of Intevac common stock to Intevac’s employees through Intevac’s employee benefit plans generated cash of $1.9 million. Tax payments related to the net share settlement of restricted stock units were $364,000. Cash used to repurchase shares of common stock under the Company’s stock repurchase program totaled $393,000 for the nine months ended September 26, 2020.

Intevac’s investment portfolio consists principally of investment grade money market mutual funds, U.S. Treasury and agency securities, certificates of deposit, commercial paper and corporate bonds. Intevac regularly monitors the credit risk in its investment portfolio and takes measures, which may include the sale of certain securities, to manage such risks in accordance with its investment policies.

As of September 26, 2020, approximately $14.3 million of cash and cash equivalents and $3.4 million of short term investments were domiciled in foreign tax jurisdictions. Intevac expects a significant portion of these funds to remain offshore in the short term. If the Company chose to repatriate these funds to the United States, it would be required to accrue and pay additional taxes on any portion of the repatriation subject to foreign withholding taxes.

Intevac believes that its existing cash, cash equivalents and investments will be sufficient to meet its cash requirements for the foreseeable future. Intevac intends to undertake approximately $1.0 million to $1.6 million in capital expenditures during the remainder of 2020.

Off-Balance Sheet Arrangements

Off-balance sheet firm commitments relating to outstanding letters of credit amounted to approximately $787,000 as of September 26, 2020. These letters of credit and bank guarantees are collateralized by $787,000 of restricted cash. We do not maintain any other off-balance sheet arrangements, transactions, obligations, or other relationships that would be expected to have a material current or future effect on the consolidated financial statements.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported. Intevac’s significant accounting policies are described in Note 1 to the consolidated financial statements included in Item 8 of Intevac’s Annual Report on Form 10-K filed on February 12, 2020. Certain of these significant accounting policies are considered to be critical accounting policies, as defined below.

A critical accounting policy is defined as one that is both material to the presentation of Intevac’s financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on Intevac’s financial conditions and results of operations. Specifically, critical accounting estimates have the following attributes: 1) Intevac is required to make assumptions about matters that are highly uncertain at the time of the estimate; and 2) different estimates Intevac could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on Intevac’s financial condition or results of operations.

32

Estimates and assumptions about future events and their effects cannot be determined with certainty. Intevac bases its estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as Intevac’s operating environment changes. These changes have historically been minor and have been included in the consolidated financial statements as soon as they become known. In addition, management is periodically faced with uncertainties, the outcomes of which are not within its control and will not be known for prolonged periods of time. Many of these uncertainties are discussed in the section below entitled “Risk Factors.” Based on a critical assessment of Intevac’s accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that Intevac’s consolidated financial statements are fairly stated in accordance with US GAAP, and provide a meaningful presentation of Intevac’s financial condition and results of operation.

For a description of critical accounting policies that affect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements, refer to our Annual Report on Form 10-K for the year ended December 28, 2019 filed with the SEC on February 12, 2020. There have been no material changes to our critical accounting policies during the nine months ended September 26, 2020.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable to smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Intevac maintains a set of disclosure controls and procedures that are designed to ensure that information relating to Intevac required to be disclosed in periodic filings under the Securities Exchange Act of 1934, or Exchange Act, is recorded, processed, summarized and reported in a timely manner under the Exchange Act. In connection with the filing of this Form 10-Q for the quarter ended September 26, 2020, as required under Rule 13a-15(e) of the Exchange Act, an evaluation was carried out under the supervision and with the participation of management, including the Chief Executive Officer (the “CEO”) and Chief Financial Officer (the “CFO”), of the effectiveness of Intevac’s disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, Intevac’s CEO and CFO concluded that our disclosure controls and procedures were effective as of September 26, 2020.

Attached as exhibits to this Quarterly Report are certifications of the CEO and the CFO, which are required in accordance with Rule 13a-14 of the Exchange Act. This Controls and Procedures section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Definition of Disclosure Controls

Disclosure controls are controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls are also designed to ensure that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls include components of our internal control over financial reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the U.S. To the extent that components of our internal control over financial reporting are included within our disclosure controls, they are included in the scope of our quarterly controls evaluation.

Limitations on the Effectiveness of Controls

Intevac’s management, including the CEO and CFO, does not expect that Intevac’s disclosure controls or Intevac’s internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Intevac have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

33

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, Intevac’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, Intevac is involved in claims and legal proceedings that arise in the ordinary course of business. Intevac expects that the number and significance of these matters will increase as Intevac’s business expands. Any claims or proceedings against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time, result in the diversion of significant operational resources, or require us to enter into royalty or licensing agreements which, if required, may not be available on terms favorable to us or at all. Intevac is not presently a party to any lawsuit or proceeding that, in Intevac’s opinion, is likely to seriously harm Intevac’s business.

Item 1A. Risk Factors

The following factors could materially affect Intevac’s business, financial condition or results of operations and should be carefully considered in evaluating the Company and its business, in addition to other information presented elsewhere in this report.

The industries we serve are cyclical, volatile and unpredictable.

A significant portion of our revenue is derived from the sale of equipment used to manufacture commodity technology products such as disk drives, PV solar cells and cell phones. This subjects us to business cycles, the timing, length and volatility of which can be difficult to predict. When demand for commodity technology products exceeds production capacity, then demand for new capital equipment such as ours tends to be amplified. Conversely, when supply of commodity technology products exceeds demand, then demand for new capital equipment such as ours tends to be depressed. We cannot predict with any certainty when these cycles will begin or end. Our sales of systems for magnetic disk production increased in 2016 as a customer began upgrading the technology level of its manufacturing capacity. Sales of systems and upgrades for magnetic disk production in 2017 and 2018 were higher than in 2016 as this customer’s technology upgrade continued. Sales of systems and upgrades for magnetic disk production in 2019 were slightly down from the levels in 2018 as this customer took delivery of four systems. Intevac expects sales of systems and upgrades for magnetic disk production in 2020 will be at levels lower from the levels in 2019.

Our equipment represents only a portion of the capital expenditure that our customers incur when they upgrade or add production capacity. Accordingly, our customers generally commit to making large capital expenditures far in excess of the cost of our systems alone when they decide to purchase our systems. The magnitude of these capital expenditures requires our customers to have access to large amounts of capital. Our customers generally reduce their level of capital investment during downturns in the overall economy or during a downturn in their industries.

In recent years the photovoltaic (solar) market has undergone a downturn, which is likely to impact our sales of PV equipment. The solar industry from time to time experiences periods of structural imbalance between supply and demand, and such periods put intense pressure on our customers’ pricing. The solar industry is currently in such a period. Competition in solar markets globally and across the solar value chain is intense, and could remain that way for an extended period of time. During any such period, solar module manufacturers may reduce their sales prices in response to competition, even below their manufacturing costs, in order to generate sales and may do so for a sustained period of time. As a result, our customers may be unable to sell their solar modules or systems at attractive prices or for a profit during a period of excess supply of solar modules, which would adversely affect their results of operations and their ability to make capital investments such as purchasing our products.

34

We must effectively manage our resources and production capacity to meet rapidly changing demand. Our business experiences rapid growth and contraction, which stresses our infrastructure, internal systems and managerial resources. During periods of increasing demand for our products, we must have sufficient manufacturing capacity and inventory to meet customer demand; attract, retain and motivate a sufficient number of qualified individuals; and effectively manage our supply chain. During periods of decreasing demand for our products, we must be able to align our cost structure with prevailing market conditions; motivate and retain key employees and effectively manage our supply chain.

The impact of the COVID-19 outbreak, or similar global health concerns, could negatively impact our operations, supply chain and customer base.

The COVID-19 outbreak has severely restricted the level of economic activity around the world, which may impact demand for our products. Our operations and supply chains for certain of our products or services could be negatively impacted by the regional or global outbreak of illnesses, including COVID-19. Any quarantines, labor shortages or other disruptions to our operations, or those of our suppliers or customers, may adversely impact our sales and operating results. In addition, a significant outbreak, epidemic, or pandemic of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, including those in which we operate, resulting in an economic downturn that could affect the supply or demand for our products and services. Our factory in Singapore was given notice by the Singapore government to suspend all on-site activities on April 27, 2020. We appealed this notice and were provided an exemption on May 14, 2020. We were temporarily required to limit the number of employees on site at our Singapore factory but these restrictions were lifted on June 2, 2020. We are unable to accurately predict the possible future effect on the Company, which could be material to our 2020 results, and which is highly dependent on the breadth and duration of the outbreak and could be affected by other factors we are not currently able to predict, including new information which may emerge concerning the severity of COVID-19, the success of actions taken to contain or treat COVID-19, and reactions by consumers, companies, governmental entities and capital markets. Any widespread growth in infections, or travel restrictions, quarantines or site closures imposed as a result of COVID-19, could, among other things, require the Company to extend mandatory work-from-home protocols resulting in additional expenses and strain on the business as well as adversely impact its supply chain.

Sales of our equipment are primarily dependent on our customers’ upgrade and capacity expansion plans and whether our customers select our equipment.

We have no control over our customers’ upgrade and capacity expansion plans, and we cannot be sure they will select, or continue to select, our equipment when they upgrade or expand their capacity. The sales cycle for our equipment systems can be a year or longer, involving individuals from many different areas of Intevac and numerous product presentations and demonstrations for our prospective customers. Our sales process also commonly includes production of samples and customization of our products. We do not typically enter into long-term contracts with our customers, and until an order is actually submitted by a customer there is no binding commitment to purchase our systems. In some cases, orders are also subject to customer acceptance or other criteria even in the case of a binding agreement.

Sales of new manufacturing systems are also dependent on obsolescence and replacement of the installed base of our customers’ existing equipment with newer, more capable equipment. If upgrades are developed that extend the useful life of the installed base of systems, then we tend to sell more upgrade products and fewer new systems, which can significantly reduce total revenue.

Our 200 Lean HDD customers also experience competition from companies that produce alternative storage technologies like flash memory, which offer smaller size, lower power consumption and more rugged designs. These storage technologies are being used increasingly in enterprise applications and smaller form factors such as tablets, smart-phones, ultra-books, and notebook PCs instead of hard disk drives. Tablet computing devices and smart-phones have never contained, nor are they likely in the future to contain, a disk drive. Products using alternative technologies, such as flash memory, optical storage and other storage technologies are becoming increasingly common and could become a significant source of competition to particular applications of the products of our 200 Lean HDD customers, which could adversely affect our results of operations. If alternative technologies, such as flash memory, replace hard disk drives as a significant method of digital storage, then demand for our hard disk manufacturing products would decrease.

The Photonics business is also subject to long sales cycles because many of its products, such as our military imaging products, often must be designed into the customers’ end products, which are often complex state-of-the-art products. These development cycles are typically multi-year, and our sales are contingent on our customers successfully integrating our product into their product, completing development of their product and then obtaining production orders for their product from the U.S. government or its allies.

35

We operate in an intensely competitive marketplace, and our competitors have greater resources than we do.

In the market for our disk sputtering systems, we experience competition primarily from Canon Anelva, which has sold a substantial number of systems worldwide. In the PV equipment market, Intevac faces competition from large established competitors including Centrotherm Photovoltaics, Jusung, Kingston and Von Ardenne. In the market for our military imaging products we experience competition from companies such as Elbit Systems and L-3 Communications. Some of our competitors have substantially greater financial, technical, marketing, manufacturing and other resources than we do, especially in the DCP and PV equipment markets. Our competitors may develop enhancements to, or future generations of, competitive products that offer superior price or performance features, and new competitors may enter our markets and develop such enhanced products. Moreover, competition for our customers is intense, and our competitors have historically offered substantial pricing concessions and incentives to attract our customers or retain their existing customers.

Our growth depends on development of technically advanced new products and processes.

We have invested heavily, and continue to invest, in the development of new products, such as our 200 Lean HDD and other PVD systems, our coating systems for DCP, our solar systems for PV applications, our digital night-vision products and our near-eye display products. Our success in developing and selling new products depends upon a variety of factors, including our ability to: predict future customer requirements; make technological advances; achieve a low total cost of ownership for our products; introduce new products on schedule; manufacture products cost-effectively including transitioning production to volume manufacturing; commercialize and attain customer acceptance of our products; and achieve acceptable and reliable performance of our new products in the field. Our new product decisions and development commitments must anticipate continuously evolving industry requirements significantly in advance of sales. In addition, we are attempting to expand into new or related markets, including the PV and display cover glass markets. Our expansion into the PV and cover glass markets is dependent upon the success of our customers’ development plans. To date we have not recognized material revenue from such products. Failure to correctly assess the size of the markets, to successfully develop cost effective products to address the markets or to establish effective sales and support of the new products would have a material adverse effect on future revenues and profits. In addition, if we invest in products for which the market does not develop as anticipated, we may incur significant charges related to such investments.

Rapid technological change in our served markets requires us to rapidly develop new technically advanced products. Our future success depends in part on our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products have reliability or quality problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance and payment for new products and additional service and warranty expenses.

We are exposed to risks associated with a highly concentrated customer base.

Historically, a significant portion of our revenue in any particular period has been attributable to sales of our disk sputtering systems to a limited number of customers. This concentration of customers, when combined with changes in the customers’ specific capacity plans and market share shifts can lead to extreme variability in our revenue and financial results from period to period.

The concentration of our customer base may enable our customers to demand pricing and other terms unfavorable to Intevac, and makes us more vulnerable to changes in demand by or issues with a given customer. Orders from a relatively limited number of manufacturers have accounted for, and will likely continue to account for, a substantial portion of our revenues. The loss of one of these large customers, or delays in purchasing by them, could have a material and adverse effect on our revenues.

Our operating results fluctuate significantly from quarter to quarter, which can lead to volatility in the price of our common stock.

Our quarterly revenues and common stock price have fluctuated significantly. We anticipate that our revenues, operating margins and common stock price will continue to fluctuate for a variety of reasons, including: (1) changes in the demand, due to seasonality, cyclicality and other factors in the markets for computer systems, storage subsystems and consumer electronics containing disks as well as cell phones and PV solar cells our customers produce with our systems; (2) delays or problems in the introduction and acceptance of our new products, or delivery of existing products; (3) timing of orders, acceptance of new systems by our customers or cancellation or delay of those orders; (4) new products, services or technological innovations by our competitors or us; (5) changes in our manufacturing costs and operating expense; (6) changes in general economic, political, stock market and industry conditions; and (7) any failure of our operating results to meet the expectations of investment research analysts or investors.

Any of these, or other factors, could lead to volatility and/or a rapid change in the trading price of our common shares. In the past, securities class action litigation has been instituted against companies following periods of volatility in the market price of their securities. Any such litigation, if instituted against Intevac, could result in substantial costs and diversion of management time and attention.

36

We may not be able to obtain export licenses from the U.S. government permitting delivery of our products to international customers.

Many of our products, especially Photonics products, require export licenses from U.S. government agencies under the Export Administration Act, the Trading with the Enemy Act of 1917, the Arms Export Act of 1976 or the International Traffic in Arms Regulations. These regulations limit the potential market for some of our products. We can give no assurance that we will be successful in obtaining all the licenses necessary to export our products. Heightened government scrutiny of export licenses for defense related products has resulted in lengthened review periods for our license applications. Exports to countries that are not considered by the U.S. government to be allies are likely to be prohibited, and even sales to U.S. allies may be limited. Failure to comply with export control laws, including identification and reporting of all exports and re-exports of controlled technology or exports made without correct license approval or improper license use could result in severe penalties and revocation of licenses. Failure to obtain export licenses, delays in obtaining licenses, or revocation of previously issued licenses would prevent us from selling the affected products outside the United States and could negatively impact our results of operations.

The Photonics business is dependent on U.S. government contracts, which are subject to fixed pricing, immediate termination and a number of procurement rules and regulations.

We sell our Photonics products and services directly to the U.S. government, as well as to prime contractors for various U.S. government programs. The U.S government is considering significant changes in the level of existing, follow-on or replacement programs. We cannot predict the impact of potential changes in priorities due to military transformations and/or the nature of future war-related activities. A shift of government priorities to programs in which we do not participate and/or reductions in funding for or the termination of programs in which we do participate, unless offset by other programs and opportunities, could have a material adverse effect on our financial position, results of operations, or cash flows.

Funding of multi-year government programs is subject to congressional appropriations, and there is no guarantee that the U.S. government will make further appropriations. Sales to the U.S. government and its prime contractors may also be affected by changes in procurement policies, budget considerations and political developments in the United States or abroad. For example, if the U.S. government is less focused on defense spending or there is a decrease in hostilities, demand for our products could decrease. The loss of funding for a government program would result in a loss of future revenues attributable to that program. The influence of any of these factors, which are beyond our control, could negatively impact our results of operations.

A significant portion of our U.S. government revenue is derived from fixed-price development and production contracts. Under fixed-price contracts, unexpected increases in the cost to develop or manufacture a product, whether due to inaccurate estimates in the bidding process, unanticipated increases in material costs, reduced production volumes, inefficiencies or other factors, are borne by us. We have experienced cost overruns in the past that have resulted in losses on certain contracts, and may experience additional cost overruns in the future. We are required to recognize the total estimated impact of cost overruns in the period in which they are first identified. Such cost overruns could have a material adverse effect on our results of operations.

Generally, government contracts contain provisions permitting termination, in whole or in part, without prior notice at the government’s convenience upon the payment of compensation only for work done and commitments made at the time of termination. We cannot ensure that one or more of the government contracts under which we, or our customers, operate will not be terminated under these circumstances. Also, we cannot ensure that we, or our customers, would be able to procure new government contracts to offset the revenues lost as a result of any termination of existing contracts, nor can we ensure that we, or our customers, will continue to remain in good standing as federal contractors.

As a U.S. government contractor we must comply with specific government rules and regulations and are subject to routine audits and investigations by U.S. government agencies. If we fail to comply with these rules and regulations, the results could include: (1) reductions in the value of our contracts; (2) reductions in amounts previously billed and recognized as revenue; (3) contract modifications or termination; (4) the assessment of penalties and fines; and (5) suspension or debarment from government contracting or subcontracting for a period of time or permanently.

Our business could be negatively impacted by cyber and other security threats or disruptions.

As a defense contractor, we face various cyber and other security threats, including espionage and attempts to gain unauthorized access to sensitive information and networks. Although we utilize various procedures and controls to monitor and mitigate the risk of these threats, there can be no assurance that these procedures and controls will be sufficient. These threats could lead to losses of sensitive information or capabilities; financial liabilities and damage to our reputation. If we are unable to maintain compliance with security standards applicable to defense contractors, we could lose business or suffer reputational harm.

37

Cyber threats to businesses in general are evolving and include, but are not limited to, malicious software, destructive malware, attempts to gain unauthorized access to data, disruption or denial of service attacks, and other electronic security breaches that could lead to disruptions in our systems, unauthorized release of confidential, personal or otherwise protected information (ours or that of our employees, customers or partners), and corruption of data, networks or systems. In addition, we could be impacted by cyber threats or other disruptions or vulnerabilities found in products we use or in our partners’ or customers’ systems that are used in connection with our business. These events, if not prevented or effectively mitigated, could damage our reputation, require remedial actions and lead to loss of business, regulatory actions, potential liability and other financial losses.

Changes to our effective tax rate affect our results of operations.

As a global company, we are subject to taxation in the United States, Singapore and various other countries. Significant judgment is required to determine and estimate worldwide tax liabilities. Our future effective tax rate could be affected by: (1) changes in tax laws; (2) the allocation of earnings to countries with differing tax rates; (3) changes in worldwide projected annual earnings in current and future years: (4) accounting pronouncements; or (5) changes in the valuation of our deferred tax assets and liabilities. Although we believe our tax estimates are reasonable, there can be no assurance that any final determination will not be different from the treatment reflected in our historical income tax provisions and accruals, which could result in additional payments by Intevac.

Our success depends on international sales and the management of global operations.

In previous years, the majority of our revenues have come from regions outside the United States. Most of our international sales are to customers in Asia, which includes products shipped to overseas operations of U.S. companies. We currently have manufacturing facilities in California and Singapore and international customer support offices in Singapore, China, and Malaysia. We expect that international sales will continue to account for a significant portion of our total revenue in future years. Certain of our suppliers are also located outside the United States.

Managing our global operations presents challenges including, but not limited to, those arising from: (1) global trade issues; (2) variations in protection of intellectual property and other legal rights in different countries; (3) concerns of U.S. governmental agencies regarding possible national commercial and/or security issues posed by growing manufacturing business in Asia; (4) fluctuation of interest rates, raw material costs, labor and operating costs, and exchange rates; (5) variations in the ability to develop relationships with suppliers and other local businesses; (6) changes in the laws and regulations of the United States, including export restrictions, and other countries, as well as their interpretation and application; (7) the need to provide technical and spares support in different locations; (8) political and economic instability; (9) cultural differences; (10) varying government incentives to promote development; (11) shipping costs and delays; (12) adverse conditions in credit markets; (13) variations in tariffs, quotas, tax codes and other market barriers; and (14) barriers to movement of cash.

We must regularly assess the size, capability and location of our global infrastructure and make appropriate changes to address these issues.

Difficulties in integrating past or future acquisitions could adversely affect our business.

We have completed a number of acquisitions and dispositions during our operating history. We have spent and may continue to spend significant resources identifying and pursuing future acquisition opportunities. Acquisitions involve numerous risks including: (1) difficulties in integrating the operations, technologies and products of the acquired companies; (2) the diversion of our management’s attention from other business concerns; and (3) the potential loss of key employees of the acquired companies. Failure to achieve the anticipated benefits of the prior and any future acquisitions or to successfully integrate the operations of the companies we acquire could have a material and adverse effect on our business, financial condition and results of operations. Any future acquisitions could also result in potentially dilutive issuance of equity securities, acquisition or divestiture-related write-offs or the assumption of debt and contingent liabilities. In addition, we have made and will continue to consider making strategic divestitures. With any divestiture, there are risks that future operating results could be unfavorably impacted if targeted objectives, such as cost savings, are not achieved or if other business disruptions occur as a result of the divestiture or activities related to the divestiture.

Our success is dependent on recruiting and retaining a highly talented work force.

Our employees are vital to our success, and our key management, engineering and other employees are difficult to replace. We do not maintain key person life insurance on any of our employees. The expansion of high technology companies worldwide has increased demand and competition for qualified personnel, and has made companies increasingly protective of prior employees. It may be difficult for us to locate employees who are not subject to non-competition agreements and other restrictions.

The majority of our U.S. operations are located in California where the cost of living and of recruiting employees is high. Our operating results depend, in large part, upon our ability to retain and attract qualified management, engineering, marketing, manufacturing, customer support, sales and administrative personnel. Furthermore, we compete with industries such as the hard disk drive, semiconductor, and solar industries for skilled employees. Failure to retain existing key personnel, or to attract, assimilate or retain additional highly qualified employees to meet our needs in the future, could have a material and adverse effect on our business, financial condition and results of operations.

38

We are dependent on certain suppliers for parts used in our products.

We are a manufacturing business. Purchased parts constitute the largest component of our product cost. Our ability to manufacture depends on the timely delivery of parts, components and subassemblies from suppliers. We obtain some of the key components and subassemblies used in our products from a single supplier or a limited group of suppliers. If any of our suppliers fail to deliver quality parts on a timely basis, we may experience delays in manufacturing, which could result in delayed product deliveries, increased costs to expedite deliveries or develop alternative suppliers, or require redesign of our products to accommodate alternative suppliers. Some of our suppliers are thinly capitalized and may be vulnerable to failure.

Our business depends on the integrity of our intellectual property rights.

The success of our business depends upon the integrity of our intellectual property rights, and we cannot ensure that: (1) any of our pending or future patent applications will be allowed or that any of the allowed applications will be issued as patents or will issue with claims of the scope we sought; (2) any of our patents will not be invalidated, deemed unenforceable, circumvented or challenged; (3) the rights granted under our patents will provide competitive advantages to us; (4) other parties will not develop similar products, duplicate our products or design around our patents; or (5) our patent rights, intellectual property laws or our agreements will adequately protect our intellectual property or competitive position.

From time to time, we have received claims that we are infringing third parties’ intellectual property rights or seeking to invalidate our rights. We cannot ensure that third parties will not in the future claim that we have infringed current or future patents, trademarks or other proprietary rights relating to our products. Any claims, with or without merit, could be time-consuming, result in costly litigation, cause product shipment delays or require us to enter into royalty or licensing agreements. Such royalty or licensing agreements, if required, may not be available on terms acceptable to us.

We could be involved in litigation.

From time to time we may be involved in litigation of various types, including litigation alleging infringement of intellectual property rights and other claims and customer disputes. Litigation is expensive, subjects us to the risk of significant damages and requires significant management time and attention and could have a material and adverse effect on our business, financial condition and results of operations.

We are subject to risks of non-compliance with environmental and other governmental regulations.

We are subject to a variety of governmental regulations relating to the use, storage, discharge, handling, emission, generation, manufacture, treatment and disposal of toxic or otherwise hazardous substances, chemicals, materials or waste. If we fail to comply with current or future regulations, such failure could result in suspension of our operations, alteration of our manufacturing process, remediation costs or substantial civil penalties or criminal fines against us or our officers, directors or employees. Additionally, these regulations could require us to acquire expensive remediation or abatement equipment and incur substantial expenses to comply with them.

Business interruptions could adversely affect our operations.

Our operations are vulnerable to interruption by fire, earthquake, floods or other natural disaster, quarantines or other disruptions associated with infectious diseases, national catastrophe, terrorist activities, war, disruptions in our computing and communications infrastructure due to power loss, telecommunications failure, human error, physical or electronic security breaches and computer viruses, and other events beyond our control. We do not have a detailed disaster recovery plan. Despite our implementation of network security measures, our tools and servers may be vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering with our computer systems and tools located at customer sites. Political instability could cause us to incur increased costs in transportation, make such transportation unreliable, increase our insurance costs or cause international currency markets to fluctuate. All these unforeseen disruptions and instabilities could have the same effects on our suppliers and their ability to timely deliver their products. In addition, we do not carry sufficient business interruption insurance to compensate us for all losses that may occur, and any losses or damages incurred by us could have a material adverse effect on our business and results of operations. For example, we self-insure earthquake risks because we believe this is the prudent financial decision based on the high cost of the limited coverage available in the earthquake insurance market. An earthquake could significantly disrupt our operations, most of which are conducted in California. It could also significantly delay our research and engineering effort on new products, most of which is also conducted in California. We take steps to minimize the damage that would be caused by business interruptions, but there is no certainty that our efforts will prove successful.

39

We could be negatively affected as a result of a proxy contest and the actions of activist stockholders.

A proxy contest with respect to election of our directors, or other activist stockholder activities, could adversely affect our business because: (1) responding to a proxy contest and other actions by activist stockholders can be costly and time-consuming, disruptive to our operations and divert the attention of management and our employees; (2) perceived uncertainties as to our future direction caused by activist activities may result in the loss of potential business opportunities, and may make it more difficult to attract and retain qualified personnel and business partners; and (3) if individuals are elected to our Board of Directors with a specific agenda, it may adversely affect our ability to effectively and timely implement our strategic plans.

We are required to evaluate our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, and any adverse results from such evaluation could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock price.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, our management must perform evaluations of our internal control over financial reporting. Beginning in 2004, our Form 10-K has included a report by management of their assessment of the adequacy of such internal control. Additionally, our independent registered public accounting firm must publicly attest to the effectiveness of our internal control over financial reporting. We have completed the evaluation of our internal controls over financial reporting as required by Section 404 of the Sarbanes-Oxley Act. Although our assessment, testing, and evaluation resulted in our conclusion that as of December 28, 2019, our internal controls over financial reporting were effective, we cannot predict the outcome of our testing in future periods. Ongoing compliance with this requirement is complex, costly and time-consuming. If Intevac fails to maintain effective internal control over financial reporting; our management does not timely assess the adequacy of such internal control; or our independent registered public accounting firm does not deliver an unqualified opinion as to the effectiveness of our internal control over financial reporting, then we could be subject to restatement of previously reported financial results, regulatory sanctions and a decline in the public’s perception of Intevac, which could have a material and adverse effect on our business, financial condition and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. On August 15, 2018, Intevac’s Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of $40.0 million. At September 26, 2020, $10.4 million remains available for future stock repurchases under the repurchase program. Intevac did not make any common stock repurchases during the three months ended September 26, 2020.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed herewith:

Exhibit Number	Description
31.1	Certification of President and Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Executive Vice President, Finance and Administration, Chief Financial Officer and Treasurer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certifications Pursuant to U.S.C. 1350 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101	The following financial statements from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 26, 2020, formatted in Inline XBRL (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.

40

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* The certification attached as Exhibit 32.1 is deemed “furnished” and not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of Intevac, Inc. under the Securities Exchange Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference.

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	INTEVAC, INC.
Date: October 27, 2020	By:	/s/ WENDELL BLONIGAN
		Wendell Blonigan
		President, Chief Executive Officer and Director
		(Principal Executive Officer)

Date: October 27, 2020	By:	/s/ JAMES MONIZ
		James Moniz
		Executive Vice President, Finance and Administration,
		Chief Financial Officer, Secretary and Treasurer
		(Principal Financial and Accounting Officer)

42

EX-31.1

Exhibit 31.1

I, Wendell Blonigan certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 27, 2020

/s/ WENDELL BLONIGAN

Wendell Blonigan

President, Chief Executive Officer and Director

EX-31.2

Exhibit 31.2

I, James Moniz certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 27, 2020

/s/ JAMES MONIZ

James Moniz

Executive Vice President, Finance and Administration,

Chief Financial Officer, Secretary and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Wendell Blonigan, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Intevac, Inc. on Form 10-Q for the quarterly period ended September 26, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Intevac, Inc.

Date: October 27, 2020

/s/ WENDELL BLONIGAN

Wendell Blonigan

President, Chief Executive Officer and Director

I, James Moniz, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Intevac, Inc. on Form 10-Q for the quarterly period ended September 26, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Intevac, Inc.

Date: October 27, 2020

/s/ JAMES MONIZ

James Moniz

Executive Vice President, Finance and Administration, Chief Financial Officer, Secretary and Treasurer

A signed original of this written statement required by Section 906 has been provided to Intevac, Inc. and will be retained by Intevac, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Intevac, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

XML

Cover Page - shares	9 Months Ended
	Sep. 26, 2020	Oct. 27, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Entity Interactive Data Current	Yes
Document Period End Date	Sep. 26, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	INTEVAC INC
Entity Central Index Key	0001001902
Current Fiscal Year End Date	--01-02
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Trading Symbol	IVAC
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	0-26946
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3125814
Entity Address, Address Line One	3560 Bassett Street
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	986-9888
Entity Small Business	true
Title of 12(b) Security	Common Stock
Entity Common Stock, Shares Outstanding		23,853,623
Security Exchange Name	NASDAQ

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Current assets:
Cash and cash equivalents	$ 27,245	$ 19,767
Short-term investments	18,342	16,720
Trade and other accounts receivable, net of allowances of $0 at both September 26, 2020 and at December 28, 2019	23,221	28,619
Inventories	23,638	24,907
Prepaid expenses and other current assets	2,031	1,504
Total current assets	94,477	91,517
Long-term investments	3,074	5,537
Restricted cash	787	787
Property, plant and equipment, net	11,552	11,598
Operating lease right-of-use-assets	8,739	10,279
Deferred income taxes and other long-term assets	5,740	6,604
Total assets	124,369	126,322
Current liabilities:
Current operating lease liabilities	2,776	2,524
Accounts payable	4,463	4,199
Accrued payroll and related liabilities	6,478	6,488
Other accrued liabilities	2,289	3,593
Customer advances	1,051	4,007
Total current liabilities	17,057	20,811
Noncurrent liabilities:
Noncurrent operating lease liabilities	7,516	9,532
Other long-term liabilities	688	186
Total noncurrent liabilities	8,204	9,718
Stockholders' equity:
Common stock, $0.001 par value	24	23
Additional paid-in capital	191,976	188,290
Treasury stock, 5,087 shares at September 26, 2020 and 4,989 shares at December 28, 2019	(29,551)	(29,158)
Accumulated other comprehensive income	502	424
Accumulated deficit	(63,843)	(63,786)
Total stockholders' equity	99,108	95,793
Total liabilities and stockholders' equity	$ 124,369	$ 126,322

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Statement of Financial Position [Abstract]
Net of allowances of trade, note and other accounts receivable	$ 0	$ 0
Common stock, par value	$ 0.001	$ 0.001
Treasury stock, shares	5,087	4,989

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Net revenues:
Total net revenues	$ 21,565	$ 26,299	$ 69,248	$ 73,441
Cost of net revenues:
Total cost of net revenues	12,265	17,521	40,372	49,066
Gross profit	9,300	8,778	28,876	24,375
Operating expenses:
Research and development	3,603	3,596	10,594	11,013
Selling, general and administrative	5,845	5,615	17,426	16,720
Total operating expenses	9,448	9,211	28,020	27,733
Income (loss) from operations	(148)	(433)	856	(3,358)
Interest income and other income (expense), net	8	126	212	448
Income (loss) before provision for income taxes	(140)	(307)	1,068	(2,910)
Provision for income taxes	217	173	1,125	1,144
Net loss	$ (357)	$ (480)	$ (57)	$ (4,054)
Net loss per share:
Basic and Diluted	$ (0.02)	$ (0.02)	$ 0.00	$ (0.18)
Weighted average common shares outstanding:
Basic and Diluted	23,771	23,130	23,605	22,992
Systems and components
Net revenues:
Total net revenues	$ 15,027	$ 21,090	$ 51,589	$ 59,965
Cost of net revenues:
Total cost of net revenues	8,389	14,180	29,969	39,741
Technology development
Net revenues:
Total net revenues	6,538	5,209	17,659	13,476
Cost of net revenues:
Total cost of net revenues	$ 3,876	$ 3,341	$ 10,403	$ 9,325

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (357)	$ (480)	$ (57)	$ (4,054)
Other comprehensive income (loss), before tax:
Other comprehensive income (loss), before tax Change in unrealized net gain on available-for-sale investments	(24)	3	29	80
Foreign currency translation gains (losses)	124	(87)	49	(87)
Other comprehensive income (loss), before tax	100	(84)	78	(7)
Income tax (expense) benefit related to items in other comprehensive income (loss)	0	0	0	0
Other comprehensive income (loss), net of tax	100	(84)	78	(7)
Comprehensive income (loss)	$ (257)	$ (564)	$ 21	$ (4,061)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Operating activities
Net loss	$ (57)	$ (4,054)
Adjustments to reconcile net loss to net cash and cash equivalents provided by (used in) operating activities:
Depreciation and amortization	2,645	2,778
Net amortization (accretion) of investment premiums and discounts	(9)	(55)
Equity-based compensation	2,186	2,260
Straight-line rent adjustment and amortization of lease incentives	(224)	(238)
Change in the fair value of acquisition-related contingent consideration	0	7
Deferred income taxes	516	552
Loss on disposal of equipment	0	87
Changes in operating assets and liabilities	2,714	(2,470)
Total adjustments	7,828	2,921
Net cash and cash equivalents provided by (used in) operating activities	7,771	(1,133)
Investing activities
Purchases of investments	(17,071)	(18,917)
Proceeds from sales and maturities of investments	17,950	18,751
Purchases of leasehold improvements and equipment	(2,329)	(3,279)
Net cash and cash equivalents used in investing activities	(1,450)	(3,445)
Financing activities
Net proceeds from issuance of common stock	1,865	1,770
Common stock repurchases	(393)	(111)
Taxes paid related to net share settlement	(364)	(296)
Payment of acquisition-related contingent consideration	0	(230)
Net cash and cash equivalents provided by financing activities	1,108	1,133
Effect of exchange rate changes on cash	49	(87)
Net increase (decrease) in cash, cash equivalents and restricted cash	7,478	(3,532)
Cash, cash equivalents and restricted cash at beginning of period	20,554	19,884
Cash, cash equivalents and restricted cash at end of period	28,032	16,352
Non-cash investing and financing activity
Additions to right-of-use-assets obtained from new operating lease liabilities	$ 128	$ 0

XML

Description of Business, Basis of Presentation and Significant Accounting Policy

9 Months Ended

Sep. 26, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business, Basis of Presentation and Significant Accounting Policy

1. Description of Business, Basis of Presentation and Significant Accounting Policy

Description of Business

Intevac, Inc. (together with its subsidiaries “Intevac,” the “Company” or “we”) is a provider of vacuum deposition equipment for a wide variety of thin-film applications, and a leading provider of digital night-vision technologies and products to the defense industry. The Company leverages its core capabilities in high-volume manufacturing of small substrates to provide process manufacturing equipment solutions to the hard disk drive (“HDD”), display cover panel (“DCP”), and photovoltaic (“PV”) solar cell industries. Intevac also provides sensors, cameras and systems for government applications such as night vision. Intevac’s customers include manufacturers of hard disk media, DCPs and solar cells as well as the U.S. government and its agencies, allies and contractors. Intevac reports two segments: Thin-film Equipment (“TFE”) and Photonics.

COVID-19 Update

In March 2020, the World Health Organization characterized the coronavirus (“COVID-19”) a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, unprecedented market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. However, we are monitoring the progression of the pandemic and its potential effect on our financial position, results of operations, and cash flows. Our factory in Singapore was given notice by the Singapore government to suspend all on-site activities on April 27, 2020. We appealed this notice and were provided an exemption on April 28, 2020. Starting May 14, 2020, we were temporarily required to limit the number of employees on site at our Singapore factory but these restrictions were lifted on June 2, 2020.

Basis of Presentation

In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac included herein have been prepared on a basis consistent with the December 28, 2019 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. Intevac’s results of operations for the three and nine months ended September 26, 2020 are not necessarily indicative of future operating results.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates.

Significant Accounting Policy

Government Grants and Credits

The Company generally records grants from governmental agencies related to income as a reduction in operating expense. Grants are recognized when there is reasonable assurance that the Company will comply with the conditions attached to the grant arrangement and the grant will be received. Reimbursements of eligible expenditures pursuant to government assistance programs are recorded as reductions of operating costs when the related costs have been incurred and there is reasonable assurance regarding collection of the claim. Grant claims not settled by the balance sheet date are recorded as receivables, provided their receipt is reasonably assured. The determination of the amount of the claim, and accordingly the receivable amount, requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. In Singapore, Intevac receives government assistance under the Job Support Scheme (“JSS”). During the quarter ended September 26, 2020, the Company received $124,000 in JSS grants, of which $72,000 is reported as a reduction of cost of net revenues, $20,000 is reported as a reduction of research and development (“R&D”) expenses and $32,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations. During the nine months ended September 26, 2020, the Company received $434,000 in JSS grants, of which $252,000 is reported as a reduction of cost of net revenues, $68,000 is reported as a reduction of R&D expenses and $114,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations.

XML

Revenue

9 Months Ended

Sep. 26, 2020

Revenue from Contract with Customer [Abstract]

Revenue

2. Revenue

The following tables represent a disaggregation of revenue from contracts with customers for the three and nine months ended September 26, 2020 and September 28, 2019 along with the reportable segment for each category.

Major Products and Service Lines

TFE	Three Months Ended September 26, 2020								Three Months Ended September 28, 2019
	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		Total
Systems, upgrades and spare parts	$	7,601	$	—	$	131	$	7,732	$	7,737	$	—	$	8,225	$	15,962
Field service		1,635		—		—		1,635		1,109		—		45		1,154
Total TFE net revenues	$	9,236	$	—	$	131	$	9,367	$	8,846	$	—	$	8,270	$	17,116
	Nine Months Ended September 26, 2020								Nine Months Ended September 28, 2019
	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		Total
Systems, upgrades and spare parts	$	29,189	$	—	$	400	$	29,589	$	31,210	$	—	$	14,616	$	45,826
Field service		4,334		—		2		4,336		3,452		2		45		3,499
Total TFE net revenues	$	33,523	$	—	$	402	$	33,925	$	34,662	$	2	$	14,661	$	49,325

	Three Months Ended				Nine Months Ended
Photonics	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands)
Products:
Military products	$	4,947	$	3,320	$	15,758	$	8,115
Commercial products		139		81		257		581
Repair and other services		574		573		1,649		1,944
Total Photonics product net revenues		5,660		3,974		17,664		10,640
Technology development:
Firm Fixed Price (“FFP”)		5,482		3,218		15,374		7,995
Cost Plus Fixed Fee (“CPFF”)		1,056		1,991		2,285		5,479
Time and materials		—		—		—		2
Total technology development net revenues		6,538		5,209		17,659		13,476
Total Photonics net revenues	$	12,198	$	9,183	$	35,323	$	24,116

Primary Geographical Markets

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	1,764	$	12,079	$	13,843	$	478	$	9,050	$	9,528
Asia		7,536		—		7,536		16,638		—		16,638
Europe		67		119		186		—		133		133
Total net revenues	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299

	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	2,596	$	35,060	$	37,656	$	995	$	23,578	$	24,573
Asia		31,262		—		31,262		48,330		—		48,330
Europe		67		263		330		—		538		538
Total net revenues	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

Timing of Revenue Recognition

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
Products transferred at a point in time	$	9,367	$	574	$	9,941	$	17,116	$	573	$	17,689
Products and services transferred over time		—		11,624		11,624		—		8,610		8,610
	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299
	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
Products transferred at a point in time	$	33,925	$	1,649	$	35,574	$	49,325	$	1,944	$	51,269
Products and services transferred over time		—		33,674		33,674		—		22,172		22,172
	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

The following table reflects the changes in our contract assets, which we classify as accounts receivable, unbilled or retainage, and our contract liabilities, which we classify as deferred revenue and customer advances, for the nine months ended September 26, 2020:

	September 26, 2020		December 28, 2019		Nine Months Change
	(In thousands)
TFE:
Contract assets:
Accounts receivable, unbilled	$	560	$	760	$	(200	)
Contract liabilities:
Deferred revenue	$	399	$	320	$	79
Customer advances		1,051		4,007		(2,956	)
	$	1,450	$	4,327	$	(2,877	)
Photonics:
Contract assets:
Accounts receivable, unbilled	$	3,238	$	3,210	$	28
Retainage		123		99		24
	$	3,361	$	3,309	$	52
Contract liabilities:
Deferred revenue	$	31	$	—	$	31

Accounts receivable, unbilled in our TFE segment represents a contract asset for revenue that has been recognized in advance of billing the customer. For our system and certain upgrade sales, our TFE customers generally pay in three installments, with a portion of the system price billed upon receipt of an order, a portion of the price billed upon shipment, and the balance of the price due upon completion of installation and acceptance of the system at the customer’s factory. Accounts receivable, unbilled in our TFE segment generally represents the balance of the system price that is due upon completion of installation and acceptance, less the amount that has been deferred as revenue for the performance of the installation tasks. During the nine months ended September 26, 2020, contract assets in our TFE segment decreased by $200,000 primarily due to the subsequent invoicing of certain unbilled spare parts revenue at December 28, 2019.

Customer advances in our TFE segment generally represent a contract liability for amounts billed to the customer prior to transferring goods. The Company has elected to use the practical expedient to disregard the effect of the time value of money in a significant financing component when its payment terms are less than one year. These contract advances are liquidated when revenue is recognized. Deferred revenue in our TFE segment generally represents a contract liability for amounts billed to a customer for completed systems at the customer site that are undergoing installation and acceptance testing where transfer of control has not yet occurred, as Intevac does not yet have a demonstrated history of meeting the acceptance criteria upon the customer’s receipt of product. During the nine months ended September 26, 2020, we recognized revenue in our TFE segment of $4.0 million and $119,000 that was included in customer advances and deferred revenue, respectively, at the beginning of the period.

Accounts receivable, unbilled in our Photonics segment represents a contract asset for revenue that has been recognized in advance of billing the customer, which is common for contracts in the defense industry. In our Photonics segment, amounts are billed as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals (e.g., monthly) or upon achievement of contractual milestones. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. Our contracts with the U.S. government may also contain retainage provisions. Retainage represents a contract asset for the portion of the contract price earned by us for work performed but held for payment by the U.S. government as a form of security until satisfactory completion of the contract. The retainage is billable upon completion of the contract performance and approval of final indirect expense rates by the government. During the nine months ended September 26, 2020, contract assets in our Photonics segment increased by $52,000 primarily due to the accrual of revenue for incurred costs under FFP and CPFF contracts.

Deferred revenue in our Photonics segment generally represents a contract liability for amounts billed to the customer upon achievement of contractual milestones. These amounts are liquidated when revenue is recognized.

On September 26, 2020, we had $63.3 million of remaining performance obligations, which we also refer to as backlog. Backlog at September 26, 2020 consisted of $18.1 million of TFE backlog and $45.2 million of Photonics backlog. We expect to recognize approximately 42% of our remaining performance obligations as revenue in 2020, 30% in 2021, 18% in 2022, 9% in 2023 and 1% in 2024 and thereafter.

XML

Inventories

9 Months Ended

Sep. 26, 2020

Inventory Disclosure [Abstract]

Inventories

3. Inventories

Inventories are stated at the lower of average cost or net realizable value and consist of the following:

	September 26, 2020		December 28, 2019
	(In thousands)
Raw materials	$	11,166	$	15,286
Work-in-progress		5,732		4,748
Finished goods		6,740		4,873
	$	23,638	$	24,907

Net inventories at September 26, 2020 and December 28, 2019 included one VERTEX SPECTRA system for DCP under evaluation in a customer’s factory and one MATRIX PVD system for advance semiconductor packaging under evaluation in a customer’s factory. Net inventories at September 26, 2020 also included one VERTEX SPECTRA system for DCP at Intevac’s factory.

XML

Equity-Based Compensation

9 Months Ended

Sep. 26, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity-Based Compensation

4. Equity-Based Compensation

At September 26, 2020, Intevac had equity-based awards outstanding under the 2020 Equity Incentive Plan, the 2012 Equity Incentive Plan and the 2004 Equity Incentive Plan (together, the “Plans”) and the 2003 Employee Stock Purchase Plan (the “ESPP”). Intevac’s stockholders approved all of these plans. The Plans permit the grant of incentive or non-statutory stock options, performance-based stock options (“PSOs”), restricted stock, stock appreciation rights, restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and performance shares.

The ESPP provides that eligible employees may purchase Intevac’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market value at the entry date of the applicable offering period or at the end of each applicable purchase interval. Offering periods are generally two years in length, and consist of a series of six-month purchase intervals. Eligible employees may join the ESPP at the beginning of any six-month purchase interval. Under the terms of the ESPP, employees can choose to have up to 50% of their base earnings withheld to purchase Intevac common stock (not to exceed $25,000 per year).

Equity-based Compensation Expense

The effect of recording equity-based compensation for the three and nine months ended September 26, 2020 and September 28, 2019 was as follows:

	Three Months Ended				Nine Months Ended
	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands)
Equity-based compensation by type of award:
Stock options	$	47	$	213	$	411	$	610
RSUs		495		375		1,311		1,018
ESPP awards		316		163		464		632
Total equity-based compensation	$	858	$	751	$	2,186	$	2,260

Stock Options and ESPP

The fair value of stock options and ESPP awards is estimated at the grant date using the Black-Scholes option valuation model. The determination of fair value of stock options and ESPP awards on the date of grant using an option-pricing model is affected by Intevac’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards and actual employee stock option exercise behavior. Intevac accounts for forfeitures as they occur, rather than estimating expected forfeitures. Option activity as of September 26, 2020 and changes during the nine months ended September 26, 2020 were as follows:

	Shares			Weighted-Average Exercise Price
Options outstanding at December 28, 2019		2,096,610		$	6.63
Options granted		6,000		$	4.88
Options cancelled and forfeited		(193,461	)	$	6.68
Options exercised		(61,722	)	$	4.77
Options outstanding at September 26, 2020		1,847,427		$	6.68
Options exercisable at September 26, 2020		1,395,582		$	6.80

Intevac issued 392,088 shares of common stock under the ESPP during the nine months ended September 26, 2020.

Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Stock Options:
Weighted-average fair value of grants per share	$	—		$	1.84		$	1.82		$	2.05
Expected volatility		—			43.87	%		46.04	%		43.22	%
Risk-free interest rate		—			1.57	%		0.44	%		1.86	%
Expected term of options (in years)		—			4.32			4.39			4.56
Dividend yield		—			None			None			None
	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Stock Purchase Rights:
Weighted-average fair value of grants per share	$	2.20		$	1.45		$	2.20		$	1.73
Expected volatility		51.72	%		38.27	%		51.49	%		45.81	%
Risk-free interest rate		0.12	%		1.85	%		0.14	%		2.28	%
Expected term of purchase rights (in years)		1.26			0.75			1.24			0.91
Dividend yield		None			None			None			None

The computation of the expected volatility assumptions used in the Black-Scholes calculations for new stock option grants and ESPP purchase rights is based on the historical volatility of Intevac’s stock price, measured over a period equal to the expected term of the stock option grant or purchase right. The risk-free interest rate is based on the yield available on U.S. Treasury Strips with an equivalent remaining term. The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the equity-based awards and vesting schedules. The expected term of purchase rights represents the period of time remaining in the current offering period. The dividend yield assumption is based on Intevac’s history of not paying dividends and the assumption of not paying dividends in the future.

Performance-based stock options (“PSOs”) vest upon the achievement of certain market conditions (our stock performance) during a set performance period (typically 4 years) subject to the grantee’s continued service with Intevac through the date the applicable market condition is achieved. The fair value is based on the values calculated using a Monte Carlo simulation model on the grant date. Compensation cost is not adjusted in future periods for subsequent changes in the expected outcome of market related conditions. The compensation expense is recognized over the derived service period. We granted 37,500 of such stock options to the Chief Executive Officer in the three months ended June 29, 2019. These PSOs have a derived service period of 1.1 years.

Intevac estimated the weighted-average fair value of PSOs using the following weighted-average assumptions:

	Nine Months Ended September 28, 2019
Weighted-average fair value of grants per share	$	1.75
Expected volatility		43.43	%
Risk free interest rate		1.96	%
Expected term (in years)		4.60
Dividend yield		None

RSUs

RSU activity as of September 26, 2020 and changes during the nine months ended September 26, 2020 were as follows:

	Shares			Weighted-Average Grant Date Fair Value
Non-vested RSUs at December 28, 2019		553,355		$	6.15
Granted		658,090		$	4.85
Vested		(221,483	)	$	6.51
Cancelled and forfeited		(35,815	)	$	6.05
Non-vested RSUs at September 26, 2020		954,147		$	5.17

Time-based RSUs are converted into shares of Intevac common stock upon vesting on a one-for-one basis. Time-based RSUs typically are scheduled to vest over four years. Vesting of time-based RSUs is subject to the grantee’s continued service with Intevac. The compensation expense related to these awards is determined using the fair market value of Intevac common stock on the date of the grant, and the compensation expense is recognized over the vesting period.

In May 2020, we granted 109,465 performance-based restricted stock units (“PRSUs”) to members of our senior management. The PRSUs were issued collectively in four separate tranches with individual one-year performance periods beginning in May 2020, 2021, 2022 and 2023, respectively. Vesting of the PRSUs is based on the performance of our common stock relative to the performance of a peer group. The fair value of each PRSU award was estimated on the date of grant using a Monte Carlo simulation. PRSU activity is included in the above RSU tables. At the end of each performance measurement period, the Compensation Committee will determine the achievement against the performance objectives. Any earned PRSU awards will vest 100% after the end of the applicable performance measurement period.

Intevac estimated the weighted-average fair value of PRSUs using the following weighted-average assumptions:

	Nine Months Ended
	September 26, 2020
Weighted-average fair value of grants per share	$	3.16
Expected volatility		46.7	%
Risk-free interest rate		0.25	%
Dividend yield		None

XML

Purchased Intangible Assets

9 Months Ended

Sep. 26, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Purchased Intangible Assets

5. Purchased Intangible Assets

Details of finite-lived intangible assets by segment as of September 26, 2020 are as follows.

	September 26, 2020
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
TFE	$	7,172	$	(7,172	)	$	—
Photonics		1,215		(1,211	)		4
	$	8,387	$	(8,383	)	$	4

Total amortization expense of finite-lived intangibles for the three and nine months ended September 26, 2020 was $11,000 and $270,000, respectively. On the condensed consolidated balance sheets, purchased intangible assets is included in deferred income taxes and other long-term assets. As of September 26, 2020, future amortization expense of $4,000 is expected to be recorded in 2020.

XML

Acquisition-Related Contingent Consideration

9 Months Ended

Sep. 26, 2020

Business Combinations [Abstract]

Contingent Consideration

6. Acquisition-Related Contingent Consideration

In connection with the acquisition of Solar Implant Technologies, Inc. (“SIT”), Intevac agreed to pay to the selling shareholders in cash a revenue earnout on Intevac’s net revenues from commercial sales of certain products over a specified period up to an aggregate of $9.0 million. The earnout period terminated on June 30, 2019. There is no remaining contingent consideration obligation associated with the earnout agreement at September 26, 2020. The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the nine months ended September 28, 2019 (in thousands):

	Nine Months Ended
	September 28, 2019
Opening balance	$	223
Changes in fair value		7
Cash payments made		(230	)
Closing balance	$	—

XML

Warranty

9 Months Ended

Sep. 26, 2020

Guarantees [Abstract]

Warranty

7. Warranty

Intevac provides for the estimated cost of warranty when revenue is recognized. Intevac’s warranty is subject to contract terms and, for its HDD manufacturing, DCP manufacturing and solar cell manufacturing systems, the warranty typically ranges between 12 and 24 months from customer acceptance. During this warranty period any defective non-consumable parts are replaced and installed at no charge to the customer. Intevac uses estimated repair or replacement costs along with its historical warranty experience to determine its warranty obligation. The provision for the estimated future costs of warranty is based upon historical cost and product performance experience. Intevac exercises judgment in determining the underlying estimates.

On the condensed consolidated balance sheets, the short-term portion of the warranty provision is included in other accrued liabilities, while the long-term portion is included in other long-term liabilities. The expense associated with product warranties issued or adjusted is included in cost of net revenues on the condensed consolidated statements of operations.

The following table displays the activity in the warranty provision account for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
Opening balance	$	662		$	948		$	1,022		$	997
Expenditures incurred under warranties		(89	)		(167	)		(398	)		(592	)
Accruals for product warranties issued during the reporting period		39			427			198			829
Adjustments to previously existing warranty accruals		(57	)		(72	)		(267	)		(98	)
Closing balance	$	555		$	1,136		$	555		$	1,136

The following table displays the balance sheet classification of the warranty provision account at September 26, 2020 and at December 28, 2019:

	September 26,		December 28,
	2020		2019
	(In thousands)
Other accrued liabilities	$	425	$	846
Other long-term liabilities		130		176
Total warranty provision	$	555	$	1,022

XML

Guarantees

9 Months Ended

Sep. 26, 2020

Guarantees [Abstract]

Guarantees

8. Guarantees

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, Intevac has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at Intevac’s request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The maximum potential amount of future payments Intevac could be required to make under these indemnification obligations is unlimited; however, Intevac has a director and officer insurance policy that mitigates Intevac’s exposure and enables Intevac to recover a portion of any future amounts paid. As a result of Intevac’s insurance policy coverage, Intevac believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in Intevac’s industry, many of Intevac’s contracts provide remedies to certain third parties such as defense, settlement, or payment of judgments for intellectual property claims related to the use of its products. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.

Letters of Credit

As of September 26, 2020, we had letters of credit and bank guarantees outstanding totaling $787,000, including the standby letter of credit outstanding under the Santa Clara, California facility lease and various other guarantees with our bank. These letters of credit and bank guarantees are collateralized by $787,000 of restricted cash.

XML

Cash, Cash Equivalents and Investments

9 Months Ended

Sep. 26, 2020

Investments Debt And Equity Securities [Abstract]

Cash, Cash Equivalents and Investments

9. Cash, Cash Equivalents and Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

	September 26, 2020
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	23,829	$	—	$	—	$	23,829
Money market funds		3,416		—		—		3,416
Total cash and cash equivalents	$	27,245	$	—	$	—	$	27,245
Short-term investments:
Certificates of deposit	$	7,450	$	7	$	—	$	7,457
Commercial paper		499		1		—		500
Corporate bonds and medium-term notes		3,842		27		—		3,869
U.S. treasury and agency securities		6,481		35		—		6,516
Total short-term investments	$	18,272	$	70	$	—	$	18,342
Long-term investments:
Certificates of deposit	$	500	$	—	$	—	$	500
Corporate bonds and medium-term notes		2,572		2		—		2,574
Total long-term investments	$	3,072	$	2	$	—	$	3,074
Total cash, cash equivalents, and investments	$	48,589	$	72	$	—	$	48,661

	December 28, 2019
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	16,512	$	—	$	—	$	16,512
Money market funds		3,255		—		—		3,255
Total cash and cash equivalents	$	19,767	$	—	$	—	$	19,767
Short-term investments:
Certificates of deposit	$	3,000	$	1	$	—	$	3,001
Commercial paper		1,891		2		—		1,893
Corporate bonds and medium-term notes		6,383		25		—		6,408
U.S. treasury and agency securities		5,417		1		—		5,418
Total short-term investments	$	16,691	$	29	$	—	$	16,720
Long-term investments:
Certificates of deposit	$	499	$	1	$	—	$	500
Corporate bonds and medium-term notes		2,530		12		—		2,542
U.S. treasury and agency securities		2,494		1		—		2,495
Total long-term investments	$	5,523	$	14	$	—	$	5,537
Total cash, cash equivalents, and investments	$	41,981	$	43	$	—	$	42,024

The contractual maturities of available-for-sale securities at September 26, 2020 are presented in the following table.

	September 26, 2020
	Amortized Cost		Fair Value
	(In thousands)
Due in one year or less	$	21,688	$	21,758
Due after one through two years		3,072		3,074
	$	24,760	$	24,832

All prices for the fixed maturity securities including U.S. Treasury and agency securities, certificates of deposit, commercial paper, corporate bonds and municipal bonds are received from independent pricing services utilized by Intevac’s outside investment manager. This investment manager performs a review of the pricing methodologies and inputs utilized by the independent pricing services for each asset type priced by the vendor. In addition, on at least an annual basis, the investment manager conducts due diligence visits and interviews with each pricing vendor to verify the inputs utilized for each asset class. The due diligence visits include a review of the procedures performed by each vendor to ensure that pricing evaluations are representative of the price that would be received for a security in an orderly sale. Any pricing where the input is based solely on a broker price is deemed to be a Level 3 price. Intevac uses the pricing data obtained from its outside investment manager as the primary input to make its assessments and determinations as to the ultimate valuation of the above-mentioned securities and has not made, during the periods presented, any material adjustments to such inputs.

The following table represents the fair value hierarchy of Intevac’s available-for-sale securities measured at fair value on a recurring basis as of September 26, 2020.

	Fair Value Measurements at September 26, 2020
	Total		Level 1		Level 2
	(In thousands)
Recurring fair value measurements:
Available-for-sale securities
Money market funds	$	3,416	$	3,416	$	—
U.S. treasury and agency securities		6,516		6,516		—
Certificates of deposit		7,957		—		7,957
Commercial paper		500		—		500
Corporate bonds and medium-term notes		6,443		—		6,443
Total recurring fair value measurements	$	24,832	$	9,932	$	14,900

XML

Derivative Instruments

9 Months Ended

Sep. 26, 2020

Derivative Instrument Detail [Abstract]

Derivative Instruments

10. Derivative Instruments

The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. These derivatives are carried at fair value with changes recorded in interest income and other income (expense), net in the condensed consolidated statements of operations. Changes in the fair value of these derivatives are largely offset by re-measurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. The derivatives have original maturities of approximately 30 days.

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of September 26, 2020 and December 28, 2019:

	Notional Amounts				Derivative Liabilities
Derivative Instrument	September 26 2020		December 28, 2019		September 26, 2020				December 28, 2019
					Balance Sheet Line		Fair Value		Balance Sheet Line		Fair Value
	(In thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	871	$	1,035		(a)	$	5		(a)	$	4
Total Hedges	$	871	$	1,035			$	5			$	4

(a) Other accrued liabilities

XML

Equity

9 Months Ended

Sep. 26, 2020

Equity [Abstract]

Equity

11. Equity

Condensed Consolidated Statement of Changes in Equity

The changes in stockholders’ equity by component for the three and nine months ended September 26, 2020 and September 28, 2019, are as follows (in thousands):

	Three months ended September 26, 2020
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at June 27, 2020	$	190,290		$	(29,551	)	$	402	$	(63,486	)	$	97,655
Common stock issued under employee plans		871			—			—		—			871
Shares withheld for net share settlement of RSUs		(19	)		—			—		—			(19	)
Equity-based compensation expense		858			—			—		—			858
Net loss		—			—			—		(357	)		(357	)
Other comprehensive income		—			—			100		—			100
Balance at September 26, 2020	$	192,000		$	(29,551	)	$	502	$	(63,843	)	$	99,108

	Nine months ended September 26, 2020
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at December 28, 2019	$	188,313		$	(29,158	)	$	424	$	(63,786	)	$	95,793
Common stock issued under employee plans		1,865			—			—		—			1,865
Shares withheld for net share settlement of RSUs		(364	)		—			—		—			(364	)
Equity-based compensation expense		2,186			—			—		—			2,186
Net loss		—			—			—		(57	)		(57	)
Other comprehensive income		—			—			78		—			78
Common stock repurchases		—			(393	)		—		—			(393	)
Balance at September 26, 2020	$	192,000		$	(29,551	)	$	502	$	(63,843	)	$	99,108

	Three months ended September 28, 2019
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at June 29, 2019	$	185,489		$	(29,089	)	$	455		$	(68,508	)	$	88,347
Common stock issued under employee plans		749			—			—			—			749
Shares withheld for net share settlement of RSUs		(28	)		—			—			—			(28	)
Equity-based compensation expense		751			—			—			—			751
Net loss		—			—			—			(480	)		(480	)
Other comprehensive loss		—			—			(84	)		—			(84	)
Common stock repurchases		—			(69	)		—			—			(69	)
Balance at September 28, 2019	$	186,961		$	(29,158	)	$	371		$	(68,988	)	$	89,186

	Nine months ended September 28, 2019
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at December 29, 2018	$	183,227		$	(29,047	)	$	378		$	(64,934	)	$	89,624
Common stock issued under employee plans		1,770			—			—			—			1,770
Shares withheld for net share settlement of RSUs		(296	)		—			—			—			(296	)
Equity-based compensation expense		2,260			—			—			—			2,260
Net loss		—			—			—			(4,054	)		(4,054	)
Other comprehensive loss		—			—			(7	)		—			(7	)
Common stock repurchases		—			(111	)		—			—			(111	)
Balance at September 28, 2019	$	186,961		$	(29,158	)	$	371		$	(68,988	)	$	89,186

Accumulated Other Comprehensive Income

The changes in accumulated other comprehensive income by component for the three and nine months ended September 26, 2020 and September 28, 2019, are as follows.

	Three Months Ended									Nine Months Ended
	September 26, 2020
	Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total			Foreign currency			Unrealized holding gains on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	306		$	96		$	402		$	381		$	43		$	424
Other comprehensive income (loss) before reclassification		124			(24	)		100			49			29			78
Amounts reclassified from other comprehensive income (loss)		—			—			—			—			—			—
Net current-period other comprehensive income		124			(24	)		100			49			29			78
Ending balance	$	430		$	72		$	502		$	430		$	72		$	502
	Three Months Ended									Nine Months Ended
	September 28, 2019
	Foreign currency			Unrealized holding gains on available-for-sale investments			Total			Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	405		$	50		$	455		$	405		$	(27	)	$	378
Other comprehensive income (loss) before reclassification		(87	)		3			(84	)		(87	)		80			(7	)
Amounts reclassified from other comprehensive income (loss)		—			—			—			—			—			—
Net current-period other comprehensive loss		(87	)		3			(84	)		(87	)		80			(7	)
Ending balance	$	318		$	53		$	371		$	318		$	53		$	371

Stock Repurchase Program

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. On August 15, 2018, Intevac’s Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of up to $40.0 million. At September 26, 2020, $10.4 million remains available for future stock repurchases under the repurchase program.

The following table summarizes Intevac’s stock repurchases:

	Three Months Ended				Nine Months Ended
	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands, except per share amounts)
Shares of common stock repurchased		—		15		98		24
Cost of stock repurchased	$	—	$	69	$	393	$	111
Average price paid per share	$	—	$	4.65	$	3.97	$	4.67

Intevac records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If Intevac reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against the accumulated deficit.

XML

Net Loss Per Share

9 Months Ended

Sep. 26, 2020

Earnings Per Share [Abstract]

Net Loss Per Share

12. Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands, except per share amounts)
Net loss	$	(357	)	$	(480	)	$	(57	)	$	(4,054	)
Weighted-average shares – basic		23,771			23,130			23,605			22,992
Effect of dilutive potential common shares		—			—			—			—
Weighted-average shares – diluted		23,771			23,130			23,605			22,992
Net loss per share – basic	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)
Net loss per share – diluted	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)

As the Company is in a net loss position, all of the Company’s equity instruments are considered antidilutive.

XML

Segment Reporting

9 Months Ended

Sep. 26, 2020

Segment Reporting [Abstract]

Segment Reporting

13. Segment Reporting

Intevac’s two reportable segments are TFE and Photonics. Intevac’s chief operating decision-maker has been identified as the President and CEO, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Segment information is presented based upon Intevac’s management organization structure as of September 26, 2020 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to the reportable segments disclosed.

Each reportable segment is separately managed and has separate financial results that are reviewed by Intevac’s chief operating decision-maker. Each reportable segment contains closely related products that are unique to the particular segment. Segment operating profit is determined based upon internal performance measures used by the chief operating decision-maker.

Intevac derives the segment results from its internal management reporting system. The accounting policies Intevac uses to derive reportable segment results are substantially the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics, including orders, net revenues and operating income. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. Intevac manages certain operating expenses separately at the corporate level. Intevac allocates certain of these corporate expenses to the segments in an amount equal to 3% of net revenues. Segment operating income excludes interest income/expense and other financial charges and income taxes according to how a particular reportable segment’s management is measured. Management does not consider impairment charges, gains and losses on divestitures and sales of intellectual property, or unallocated costs in measuring the performance of the reportable segments.

The TFE segment designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the hard drive, solar cell and DCP industries, as well as other adjacent thin-film markets.

The Photonics segment develops compact, cost-effective, high-sensitivity digital-optical products for the capture and display of low-light images. Intevac provides sensors, cameras and systems for government applications such as night vision.

Information for each reportable segment for the three and nine months ended September 26, 2020 and September 28, 2019 is as follows:

Net Revenues

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
TFE	$	9,367		$	17,116		$	33,925		$	49,325
Photonics		12,198			9,183			35,323			24,116
Total segment net revenues	$	21,565		$	26,299		$	69,248		$	73,441
Operating Income (Loss)
	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
TFE	$	(1,661	)	$	(1,542	)	$	(4,366	)	$	(3,434	)
Photonics		3,032			2,268			9,480			3,114
Total segment operating income (loss)		1,371			726			5,114			(320	)
Unallocated costs		(1,519	)		(1,159	)		(4,258	)		(3,038	)
Income (loss) from operations		(148	)		(433	)		856			(3,358	)
Interest income and other income (expense), net		8			126			212			448
Income (loss) before provision for income taxes	$	(140	)	$	(307	)	$	1,068		$	(2,910	)

Total assets for each reportable segment as of September 26, 2020 and December 28, 2019 are as follows:

Assets

	September 26, 2020		December 28, 2019
	(In thousands)
TFE	$	45,819	$	51,153
Photonics		19,049		22,071
Total segment assets		64,868		73,224
Cash, cash equivalents and investments		48,661		42,024
Restricted cash		787		787
Deferred income taxes		5,736		6,252
Other current assets		1,145		752
Common property, plant and equipment		1,461		1,307
Common operating lease right-of-use assets		1,711		1,898
Other assets		—		78
Consolidated total assets	$	124,369	$	126,322

XML

Income Taxes

9 Months Ended

Sep. 26, 2020

Income Tax Disclosure [Abstract]

Income Taxes

14. Income Taxes

Intevac recorded income tax provisions of $217,000 and $1.1 million for the three and nine months ended September 26, 2020, respectively, and $173,000 and $1.1 million for the three and nine months ended September 28, 2019, respectively. The income tax provisions for these three and nine month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. For the three and nine month periods ended September 26, 2020 Intevac recorded income tax provisions on earnings of its international subsidiaries of $111,000 and $659,000, respectively, and recorded $98,000 and $471,000, respectively, for withholding taxes on royalties paid into the United States from Intevac’s Singapore subsidiary as discrete items. For the three and nine month periods ended September 28, 2019, Intevac recorded income tax provisions on earnings of its international subsidiaries of $48,000 and $611,000, respectively, and recorded $130,000 and $534,000, respectively, for withholding taxes on royalties paid into the United States from Intevac’s Singapore subsidiary as discrete items. For all periods presented Intevac utilized net operating loss carry-forwards to offset the impact of global intangible low-taxed income (“GILTI”). Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

The Inland Revenue Authority of Singapore (“IRAS”) conducted a review of the fiscal 2009 through 2010 tax returns of the Company’s wholly-owned subsidiary, Intevac Asia Pte. Ltd. IRAS challenged the Company’s tax position with respect to certain deductions. The Company paid all contested taxes and the related interest to have the right to defend its position under Singapore tax law. In October 2020, the Company received an unfavorable decision on its appeal to the Singapore High Court. Management is considering a further appeal to the Court of Appeal, which must be made within thirty days of the High Court decision. As of September 26, 2020, the $915,000 contested tax deposit reported on its balance sheet was fully reserved.

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. The CARES Act includes several significant provisions for corporations, including the usage of net operating losses and payroll benefits. Several foreign (non-U.S.) jurisdictions in which we operate have taken similar economic stimulus measures. The Company evaluated the provisions of the CARES Act and other non-U.S. economic measures and determined the impact on our financial position at September 26, 2020 and on the results of operations and cash flows for the three and nine months then ended as well as anticipated future benefits for the remainder of fiscal 2020 to be as follows.

Under the CARES Act, we have elected to defer payment, on an interest-free basis, of the employer portion of social security payroll taxes incurred from March 27, 2020 to December 31, 2020. One-half of such deferral amount will become due on each of December 31, 2021 and December 31, 2022. We elected to utilize this deferral program to delay payment of approximately $763,000 of the employer portion of payroll taxes estimated to be incurred between March 27, 2020 and December 31, 2020. The deferred payroll tax liability of $547,000 at September 26, 2020 is included in other long-term liabilities on the condensed consolidated balance sheets. The Company will also utilize the employee retention tax credit under the CARES Act for certain qualifying employee salary and wage expenditures. Tax benefits under the employee retention tax credit are not expected to be significant. Additionally, the CARES Act accelerates the timing of the refund for alternative minimum tax (“AMT”) credits. The entire balance of the income tax refund receivable of $157,000 was received in July 2020.

In Singapore, Intevac receives government assistance under the Job Support Scheme (“JSS”). The purpose of the JSS is to provide wage support to employers to help them retain their local employees. Under the JSS, Intevac expects to receive approximately $554,000 in JSS grants in fiscal 2020. During the quarter ended September 26, 2020, the Company received $124,000 in JSS grants, of which $72,000 is reported as a reduction of cost of net revenues, $20,000 is reported as a reduction of R&D expenses and $32,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations. During the nine months ended September 26, 2020, the Company received $434,000 in JSS grants, of which $252,000 is reported as a reduction of cost of net revenues, $68,000 is reported as a reduction of R&D expenses and $114,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations.

XML

Restructuring Charges

9 Months Ended

Sep. 26, 2020

Restructuring and Related Activities [Abstract]

Restructuring Charges

15. Restructuring Charges

During the third quarter of fiscal 2020, Intevac substantially completed implementation of the 2020 cost reduction plan (the “Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 1.0 percent. The cost of implementing the Cost Reduction Plan was reported under cost of net revenues and operating expenses in the condensed consolidated statements of operations. Substantially all cash outlays in connection with the Cost Reduction Plan occurred in the third quarter of fiscal 2020. Implementation of the Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $864,000 on an annual basis.

The changes in restructuring reserves, which resulted from cash-based severance payments and other employee-related costs, associated with the Cost Reduction Plan for the three and nine months ended September 26, 2020 were as follows.

	Three and Nine Months Ended September 26, 2020
	(In thousands)
Beginning balance	$	—
Provision for restructuring reserves		103
Cash payments made		(103	)
Ending balance	$	—

XML

Contingencies

9 Months Ended

Sep. 26, 2020

Commitments and Contingencies Disclosure [Abstract]

Contingencies

16. Contingencies

From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.

XML

Description of Business, Basis of Presentation and Significant Accounting Policy (Policies)

9 Months Ended

Sep. 26, 2020

Policy Text Block [Abstract]

Government Grants and Credits

Government Grants and Credits

The Company generally records grants from governmental agencies related to income as a reduction in operating expense. Grants are recognized when there is reasonable assurance that the Company will comply with the conditions attached to the grant arrangement and the grant will be received. Reimbursements of eligible expenditures pursuant to government assistance programs are recorded as reductions of operating costs when the related costs have been incurred and there is reasonable assurance regarding collection of the claim. Grant claims not settled by the balance sheet date are recorded as receivables, provided their receipt is reasonably assured. The determination of the amount of the claim, and accordingly the receivable amount, requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. In Singapore, Intevac receives government assistance under the Job Support Scheme (“JSS”). During the quarter ended September 26, 2020, the Company received $124,000 in JSS grants, of which $72,000 is reported as a reduction of cost of net revenues, $20,000 is reported as a reduction of research and development (“R&D”) expenses and $32,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations. During the nine months ended September 26, 2020, the Company received $434,000 in JSS grants, of which $252,000 is reported as a reduction of cost of net revenues, $68,000 is reported as a reduction of R&D expenses and $114,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations.

XML

Revenue (Tables)

9 Months Ended

Sep. 26, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue from Contracts with Customers

The following tables represent a disaggregation of revenue from contracts with customers for the three and nine months ended September 26, 2020 and September 28, 2019 along with the reportable segment for each category.

Major Products and Service Lines

TFE	Three Months Ended September 26, 2020								Three Months Ended September 28, 2019
	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		Total
Systems, upgrades and spare parts	$	7,601	$	—	$	131	$	7,732	$	7,737	$	—	$	8,225	$	15,962
Field service		1,635		—		—		1,635		1,109		—		45		1,154
Total TFE net revenues	$	9,236	$	—	$	131	$	9,367	$	8,846	$	—	$	8,270	$	17,116
	Nine Months Ended September 26, 2020								Nine Months Ended September 28, 2019
	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		Total
Systems, upgrades and spare parts	$	29,189	$	—	$	400	$	29,589	$	31,210	$	—	$	14,616	$	45,826
Field service		4,334		—		2		4,336		3,452		2		45		3,499
Total TFE net revenues	$	33,523	$	—	$	402	$	33,925	$	34,662	$	2	$	14,661	$	49,325

	Three Months Ended				Nine Months Ended
Photonics	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands)
Products:
Military products	$	4,947	$	3,320	$	15,758	$	8,115
Commercial products		139		81		257		581
Repair and other services		574		573		1,649		1,944
Total Photonics product net revenues		5,660		3,974		17,664		10,640
Technology development:
Firm Fixed Price (“FFP”)		5,482		3,218		15,374		7,995
Cost Plus Fixed Fee (“CPFF”)		1,056		1,991		2,285		5,479
Time and materials		—		—		—		2
Total technology development net revenues		6,538		5,209		17,659		13,476
Total Photonics net revenues	$	12,198	$	9,183	$	35,323	$	24,116

Primary Geographical Markets

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	1,764	$	12,079	$	13,843	$	478	$	9,050	$	9,528
Asia		7,536		—		7,536		16,638		—		16,638
Europe		67		119		186		—		133		133
Total net revenues	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299

	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
United States	$	2,596	$	35,060	$	37,656	$	995	$	23,578	$	24,573
Asia		31,262		—		31,262		48,330		—		48,330
Europe		67		263		330		—		538		538
Total net revenues	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

Timing of Revenue Recognition

	Three Months Ended						Three Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
Products transferred at a point in time	$	9,367	$	574	$	9,941	$	17,116	$	573	$	17,689
Products and services transferred over time		—		11,624		11,624		—		8,610		8,610
	$	9,367	$	12,198	$	21,565	$	17,116	$	9,183	$	26,299
	Nine Months Ended						Nine Months Ended
	September 26, 2020						September 28, 2019
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total
Products transferred at a point in time	$	33,925	$	1,649	$	35,574	$	49,325	$	1,944	$	51,269
Products and services transferred over time		—		33,674		33,674		—		22,172		22,172
	$	33,925	$	35,323	$	69,248	$	49,325	$	24,116	$	73,441

Changes in Contract Assets and Contract Liabilities

The following table reflects the changes in our contract assets, which we classify as accounts receivable, unbilled or retainage, and our contract liabilities, which we classify as deferred revenue and customer advances, for the nine months ended September 26, 2020:

	September 26, 2020		December 28, 2019		Nine Months Change
	(In thousands)
TFE:
Contract assets:
Accounts receivable, unbilled	$	560	$	760	$	(200	)
Contract liabilities:
Deferred revenue	$	399	$	320	$	79
Customer advances		1,051		4,007		(2,956	)
	$	1,450	$	4,327	$	(2,877	)
Photonics:
Contract assets:
Accounts receivable, unbilled	$	3,238	$	3,210	$	28
Retainage		123		99		24
	$	3,361	$	3,309	$	52
Contract liabilities:
Deferred revenue	$	31	$	—	$	31

XML

Inventories (Tables)

9 Months Ended

Sep. 26, 2020

Inventory Disclosure [Abstract]

Summary of Inventories

Inventories are stated at the lower of average cost or net realizable value and consist of the following:

	September 26, 2020		December 28, 2019
	(In thousands)
Raw materials	$	11,166	$	15,286
Work-in-progress		5,732		4,748
Finished goods		6,740		4,873
	$	23,638	$	24,907

XML

Equity-Based Compensation (Tables)

9 Months Ended

Sep. 26, 2020

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Effect of Recording Equity-Based Compensation

The effect of recording equity-based compensation for the three and nine months ended September 26, 2020 and September 28, 2019 was as follows:

	Three Months Ended				Nine Months Ended
	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands)
Equity-based compensation by type of award:
Stock options	$	47	$	213	$	411	$	610
RSUs		495		375		1,311		1,018
ESPP awards		316		163		464		632
Total equity-based compensation	$	858	$	751	$	2,186	$	2,260

Summary of Stock Option Activity

Option activity as of September 26, 2020 and changes during the nine months ended September 26, 2020 were as follows:

	Shares			Weighted-Average Exercise Price
Options outstanding at December 28, 2019		2,096,610		$	6.63
Options granted		6,000		$	4.88
Options cancelled and forfeited		(193,461	)	$	6.68
Options exercised		(61,722	)	$	4.77
Options outstanding at September 26, 2020		1,847,427		$	6.68
Options exercisable at September 26, 2020		1,395,582		$	6.80

Employee Stock Options Weighted-Average Assumptions

Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Stock Options:
Weighted-average fair value of grants per share	$	—		$	1.84		$	1.82		$	2.05
Expected volatility		—			43.87	%		46.04	%		43.22	%
Risk-free interest rate		—			1.57	%		0.44	%		1.86	%
Expected term of options (in years)		—			4.32			4.39			4.56
Dividend yield		—			None			None			None
	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
Stock Purchase Rights:
Weighted-average fair value of grants per share	$	2.20		$	1.45		$	2.20		$	1.73
Expected volatility		51.72	%		38.27	%		51.49	%		45.81	%
Risk-free interest rate		0.12	%		1.85	%		0.14	%		2.28	%
Expected term of purchase rights (in years)		1.26			0.75			1.24			0.91
Dividend yield		None			None			None			None

Summary of Restricted Stock Units Activity

RSU activity as of September 26, 2020 and changes during the nine months ended September 26, 2020 were as follows:

	Shares			Weighted-Average Grant Date Fair Value
Non-vested RSUs at December 28, 2019		553,355		$	6.15
Granted		658,090		$	4.85
Vested		(221,483	)	$	6.51
Cancelled and forfeited		(35,815	)	$	6.05
Non-vested RSUs at September 26, 2020		954,147		$	5.17

Employee Stock Purchase Rights Weighted-Average Assumptions

Intevac estimated the weighted-average fair value of PRSUs using the following weighted-average assumptions:

	Nine Months Ended
	September 26, 2020
Weighted-average fair value of grants per share	$	3.16
Expected volatility		46.7	%
Risk-free interest rate		0.25	%
Dividend yield		None

Performance Stock Options (PSO's)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Stock Options Weighted-Average Assumptions

Intevac estimated the weighted-average fair value of PSOs using the following weighted-average assumptions:

	Nine Months Ended September 28, 2019
Weighted-average fair value of grants per share	$	1.75
Expected volatility		43.43	%
Risk free interest rate		1.96	%
Expected term (in years)		4.60
Dividend yield		None

XML

Purchased Intangible Assets (Tables)

9 Months Ended

Sep. 26, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Information Regarding Other Acquisition Related Intangible Assets

Details of finite-lived intangible assets by segment as of September 26, 2020 are as follows.

	September 26, 2020
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
TFE	$	7,172	$	(7,172	)	$	—
Photonics		1,215		(1,211	)		4
	$	8,387	$	(8,383	)	$	4

XML

Acquisition-Related Contingent Consideration (Tables)

9 Months Ended

Sep. 26, 2020

Business Combinations [Abstract]

Reconciliation of Change in Fair Value Measurement of Contingent Consideration Liability

The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the nine months ended September 28, 2019 (in thousands):

	Nine Months Ended
	September 28, 2019
Opening balance	$	223
Changes in fair value		7
Cash payments made		(230	)
Closing balance	$	—

XML

Warranty (Tables)

9 Months Ended

Sep. 26, 2020

Guarantees [Abstract]

Schedule of Product Warranty Liability

The following table displays the activity in the warranty provision account for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
Opening balance	$	662		$	948		$	1,022		$	997
Expenditures incurred under warranties		(89	)		(167	)		(398	)		(592	)
Accruals for product warranties issued during the reporting period		39			427			198			829
Adjustments to previously existing warranty accruals		(57	)		(72	)		(267	)		(98	)
Closing balance	$	555		$	1,136		$	555		$	1,136

The following table displays the balance sheet classification of the warranty provision account at September 26, 2020 and at December 28, 2019:

	September 26,		December 28,
	2020		2019
	(In thousands)
Other accrued liabilities	$	425	$	846
Other long-term liabilities		130		176
Total warranty provision	$	555	$	1,022

XML

Cash, Cash Equivalents and Investments (Tables)

9 Months Ended

Sep. 26, 2020

Investments, All Other Investments [Abstract]

Cash, Cash Equivalents and Short-Term Investments and Long-Term Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

	September 26, 2020
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	23,829	$	—	$	—	$	23,829
Money market funds		3,416		—		—		3,416
Total cash and cash equivalents	$	27,245	$	—	$	—	$	27,245
Short-term investments:
Certificates of deposit	$	7,450	$	7	$	—	$	7,457
Commercial paper		499		1		—		500
Corporate bonds and medium-term notes		3,842		27		—		3,869
U.S. treasury and agency securities		6,481		35		—		6,516
Total short-term investments	$	18,272	$	70	$	—	$	18,342
Long-term investments:
Certificates of deposit	$	500	$	—	$	—	$	500
Corporate bonds and medium-term notes		2,572		2		—		2,574
Total long-term investments	$	3,072	$	2	$	—	$	3,074
Total cash, cash equivalents, and investments	$	48,589	$	72	$	—	$	48,661

	December 28, 2019
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	16,512	$	—	$	—	$	16,512
Money market funds		3,255		—		—		3,255
Total cash and cash equivalents	$	19,767	$	—	$	—	$	19,767
Short-term investments:
Certificates of deposit	$	3,000	$	1	$	—	$	3,001
Commercial paper		1,891		2		—		1,893
Corporate bonds and medium-term notes		6,383		25		—		6,408
U.S. treasury and agency securities		5,417		1		—		5,418
Total short-term investments	$	16,691	$	29	$	—	$	16,720
Long-term investments:
Certificates of deposit	$	499	$	1	$	—	$	500
Corporate bonds and medium-term notes		2,530		12		—		2,542
U.S. treasury and agency securities		2,494		1		—		2,495
Total long-term investments	$	5,523	$	14	$	—	$	5,537
Total cash, cash equivalents, and investments	$	41,981	$	43	$	—	$	42,024

Contractual Maturities of Available-for-Sale Securities

The contractual maturities of available-for-sale securities at September 26, 2020 are presented in the following table.

	September 26, 2020
	Amortized Cost		Fair Value
	(In thousands)
Due in one year or less	$	21,688	$	21,758
Due after one through two years		3,072		3,074
	$	24,760	$	24,832

Fair Value Hierarchy of Available-for-Sale Securities Measured at Fair Value on Recurring Basis

The following table represents the fair value hierarchy of Intevac’s available-for-sale securities measured at fair value on a recurring basis as of September 26, 2020.

	Fair Value Measurements at September 26, 2020
	Total		Level 1		Level 2
	(In thousands)
Recurring fair value measurements:
Available-for-sale securities
Money market funds	$	3,416	$	3,416	$	—
U.S. treasury and agency securities		6,516		6,516		—
Certificates of deposit		7,957		—		7,957
Commercial paper		500		—		500
Corporate bonds and medium-term notes		6,443		—		6,443
Total recurring fair value measurements	$	24,832	$	9,932	$	14,900

XML

Derivative Instruments (Tables)

9 Months Ended

Sep. 26, 2020

Derivative Instrument Detail [Abstract]

Summary of Outstanding Derivative Instruments on Gross Basis as Recorded in Consolidated Balance Sheets

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of September 26, 2020 and December 28, 2019:

	Notional Amounts				Derivative Liabilities
Derivative Instrument	September 26 2020		December 28, 2019		September 26, 2020				December 28, 2019
					Balance Sheet Line		Fair Value		Balance Sheet Line		Fair Value
	(In thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	871	$	1,035		(a)	$	5		(a)	$	4
Total Hedges	$	871	$	1,035			$	5			$	4

(a) Other accrued liabilities

XML

Equity (Tables)

9 Months Ended

Sep. 26, 2020

Equity [Abstract]

Schedule of Changes in Stockholders' Equity

The changes in stockholders’ equity by component for the three and nine months ended September 26, 2020 and September 28, 2019, are as follows (in thousands):

	Three months ended September 26, 2020
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at June 27, 2020	$	190,290		$	(29,551	)	$	402	$	(63,486	)	$	97,655
Common stock issued under employee plans		871			—			—		—			871
Shares withheld for net share settlement of RSUs		(19	)		—			—		—			(19	)
Equity-based compensation expense		858			—			—		—			858
Net loss		—			—			—		(357	)		(357	)
Other comprehensive income		—			—			100		—			100
Balance at September 26, 2020	$	192,000		$	(29,551	)	$	502	$	(63,843	)	$	99,108

	Nine months ended September 26, 2020
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at December 28, 2019	$	188,313		$	(29,158	)	$	424	$	(63,786	)	$	95,793
Common stock issued under employee plans		1,865			—			—		—			1,865
Shares withheld for net share settlement of RSUs		(364	)		—			—		—			(364	)
Equity-based compensation expense		2,186			—			—		—			2,186
Net loss		—			—			—		(57	)		(57	)
Other comprehensive income		—			—			78		—			78
Common stock repurchases		—			(393	)		—		—			(393	)
Balance at September 26, 2020	$	192,000		$	(29,551	)	$	502	$	(63,843	)	$	99,108

	Three months ended September 28, 2019
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at June 29, 2019	$	185,489		$	(29,089	)	$	455		$	(68,508	)	$	88,347
Common stock issued under employee plans		749			—			—			—			749
Shares withheld for net share settlement of RSUs		(28	)		—			—			—			(28	)
Equity-based compensation expense		751			—			—			—			751
Net loss		—			—			—			(480	)		(480	)
Other comprehensive loss		—			—			(84	)		—			(84	)
Common stock repurchases		—			(69	)		—			—			(69	)
Balance at September 28, 2019	$	186,961		$	(29,158	)	$	371		$	(68,988	)	$	89,186

	Nine months ended September 28, 2019
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at December 29, 2018	$	183,227		$	(29,047	)	$	378		$	(64,934	)	$	89,624
Common stock issued under employee plans		1,770			—			—			—			1,770
Shares withheld for net share settlement of RSUs		(296	)		—			—			—			(296	)
Equity-based compensation expense		2,260			—			—			—			2,260
Net loss		—			—			—			(4,054	)		(4,054	)
Other comprehensive loss		—			—			(7	)		—			(7	)
Common stock repurchases		—			(111	)		—			—			(111	)
Balance at September 28, 2019	$	186,961		$	(29,158	)	$	371		$	(68,988	)	$	89,186

Changes in Accumulated Other Comprehensive Income by Component

The changes in accumulated other comprehensive income by component for the three and nine months ended September 26, 2020 and September 28, 2019, are as follows.

	Three Months Ended									Nine Months Ended
	September 26, 2020
	Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total			Foreign currency			Unrealized holding gains on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	306		$	96		$	402		$	381		$	43		$	424
Other comprehensive income (loss) before reclassification		124			(24	)		100			49			29			78
Amounts reclassified from other comprehensive income (loss)		—			—			—			—			—			—
Net current-period other comprehensive income		124			(24	)		100			49			29			78
Ending balance	$	430		$	72		$	502		$	430		$	72		$	502
	Three Months Ended									Nine Months Ended
	September 28, 2019
	Foreign currency			Unrealized holding gains on available-for-sale investments			Total			Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	405		$	50		$	455		$	405		$	(27	)	$	378
Other comprehensive income (loss) before reclassification		(87	)		3			(84	)		(87	)		80			(7	)
Amounts reclassified from other comprehensive income (loss)		—			—			—			—			—			—
Net current-period other comprehensive loss		(87	)		3			(84	)		(87	)		80			(7	)
Ending balance	$	318		$	53		$	371		$	318		$	53		$	371

Schedule of Stock Repurchases

The following table summarizes Intevac’s stock repurchases:

	Three Months Ended				Nine Months Ended
	September 26, 2020		September 28, 2019		September 26, 2020		September 28, 2019
	(In thousands, except per share amounts)
Shares of common stock repurchased		—		15		98		24
Cost of stock repurchased	$	—	$	69	$	393	$	111
Average price paid per share	$	—	$	4.65	$	3.97	$	4.67

XML

Net Loss Per Share (Tables)

9 Months Ended

Sep. 26, 2020

Earnings Per Share [Abstract]

Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the three and nine months ended September 26, 2020 and September 28, 2019:

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands, except per share amounts)
Net loss	$	(357	)	$	(480	)	$	(57	)	$	(4,054	)
Weighted-average shares – basic		23,771			23,130			23,605			22,992
Effect of dilutive potential common shares		—			—			—			—
Weighted-average shares – diluted		23,771			23,130			23,605			22,992
Net loss per share – basic	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)
Net loss per share – diluted	$	(0.02	)	$	(0.02	)	$	(0.00	)	$	(0.18	)

XML

Segment Reporting (Tables)

9 Months Ended

Sep. 26, 2020

Segment Reporting [Abstract]

Information for Each Reportable Segment

Information for each reportable segment for the three and nine months ended September 26, 2020 and September 28, 2019 is as follows:

Net Revenues

	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
TFE	$	9,367		$	17,116		$	33,925		$	49,325
Photonics		12,198			9,183			35,323			24,116
Total segment net revenues	$	21,565		$	26,299		$	69,248		$	73,441
Operating Income (Loss)
	Three Months Ended						Nine Months Ended
	September 26, 2020			September 28, 2019			September 26, 2020			September 28, 2019
	(In thousands)
TFE	$	(1,661	)	$	(1,542	)	$	(4,366	)	$	(3,434	)
Photonics		3,032			2,268			9,480			3,114
Total segment operating income (loss)		1,371			726			5,114			(320	)
Unallocated costs		(1,519	)		(1,159	)		(4,258	)		(3,038	)
Income (loss) from operations		(148	)		(433	)		856			(3,358	)
Interest income and other income (expense), net		8			126			212			448
Income (loss) before provision for income taxes	$	(140	)	$	(307	)	$	1,068		$	(2,910	)

Segment Assets

Total assets for each reportable segment as of September 26, 2020 and December 28, 2019 are as follows:

Assets

	September 26, 2020		December 28, 2019
	(In thousands)
TFE	$	45,819	$	51,153
Photonics		19,049		22,071
Total segment assets		64,868		73,224
Cash, cash equivalents and investments		48,661		42,024
Restricted cash		787		787
Deferred income taxes		5,736		6,252
Other current assets		1,145		752
Common property, plant and equipment		1,461		1,307
Common operating lease right-of-use assets		1,711		1,898
Other assets		—		78
Consolidated total assets	$	124,369	$	126,322

XML

Restructuring Charges (Tables)

9 Months Ended

Sep. 26, 2020

Restructuring and Related Activities [Abstract]

Changes in Restructuring Reserves

The changes in restructuring reserves, which resulted from cash-based severance payments and other employee-related costs, associated with the Cost Reduction Plan for the three and nine months ended September 26, 2020 were as follows.

	Three and Nine Months Ended September 26, 2020
	(In thousands)
Beginning balance	$	—
Provision for restructuring reserves		103
Cash payments made		(103	)
Ending balance	$	—

XML

Description of Business, Basis of Presentation and Significant Accounting Policy - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 26, 2020	Sep. 26, 2020
Description of Business and Basis of Presentation and Significant Accounting Policies [Line Items]
Proceeds from government grants	$ 124	$ 434
Cost of Sales [Member] | Grant [Member]
Description of Business and Basis of Presentation and Significant Accounting Policies [Line Items]
Proceeds from government grants	72	252
Research and Development Expense [Member] | Grant [Member]
Description of Business and Basis of Presentation and Significant Accounting Policies [Line Items]
Proceeds from government grants	20	68
Selling, General and Administrative Expenses [Member] | Grant [Member]
Description of Business and Basis of Presentation and Significant Accounting Policies [Line Items]
Proceeds from government grants	$ 32	$ 114

XML

Revenue -Disaggregation of Revenue from Contracts with Customers (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Disaggregation of Revenue [Line Items]
Total net revenues	$ 21,565	$ 26,299	$ 69,248	$ 73,441
TFE
Disaggregation of Revenue [Line Items]
Total net revenues	9,367	17,116	33,925	49,325
TFE | Systems, Upgrades and Spare Parts
Disaggregation of Revenue [Line Items]
Total net revenues	7,732	15,962	29,589	45,826
TFE | Field Service
Disaggregation of Revenue [Line Items]
Total net revenues	1,635	1,154	4,336	3,499
Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	12,198	9,183	35,323	24,116
HDD | TFE
Disaggregation of Revenue [Line Items]
Total net revenues	9,236	8,846	33,523	34,662
HDD | TFE | Systems, Upgrades and Spare Parts
Disaggregation of Revenue [Line Items]
Total net revenues	7,601	7,737	29,189	31,210
HDD | TFE | Field Service
Disaggregation of Revenue [Line Items]
Total net revenues	1,635	1,109	4,334	3,452
DCP | TFE
Disaggregation of Revenue [Line Items]
Total net revenues				2
DCP | TFE | Systems, Upgrades and Spare Parts
Disaggregation of Revenue [Line Items]
Total net revenues
DCP | TFE | Field Service
Disaggregation of Revenue [Line Items]
Total net revenues				2
PV | TFE
Disaggregation of Revenue [Line Items]
Total net revenues	131	8,270	402	14,661
PV | TFE | Systems, Upgrades and Spare Parts
Disaggregation of Revenue [Line Items]
Total net revenues	131	8,225	400	14,616
PV | TFE | Field Service
Disaggregation of Revenue [Line Items]
Total net revenues		45	2	45
Military Products | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	4,947	3,320	15,758	8,115
Commercial Products | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	139	81	257	581
Repair and Other Services | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	574	573	1,649	1,944
Product | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	5,660	3,974	17,664	10,640
Firm Fixed Price [Member] | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	5,482	3,218	15,374	7,995
Cost Plus Fixed Fee [Member] | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	1,056	1,991	2,285	5,479
Times and Materials | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues				2
Technology Development | Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	$ 6,538	$ 5,209	$ 17,659	$ 13,476

XML

Revenue - Primary Geography Markets (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Disaggregation of Revenue [Line Items]
Total net revenues	$ 21,565	$ 26,299	$ 69,248	$ 73,441
Products Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total net revenues	9,941	17,689	35,574	51,269
Products and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total net revenues	11,624	8,610	33,674	22,172
United States
Disaggregation of Revenue [Line Items]
Total net revenues	13,843	9,528	37,656	24,573
Asia
Disaggregation of Revenue [Line Items]
Total net revenues	7,536	16,638	31,262	48,330
Europe
Disaggregation of Revenue [Line Items]
Total net revenues	186	133	330	538
TFE
Disaggregation of Revenue [Line Items]
Total net revenues	9,367	17,116	33,925	49,325
TFE | Products Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total net revenues	9,367	17,116	33,925	49,325
TFE | United States
Disaggregation of Revenue [Line Items]
Total net revenues	1,764	478	2,596	995
TFE | Asia
Disaggregation of Revenue [Line Items]
Total net revenues	7,536	16,638	31,262	48,330
TFE | Europe
Disaggregation of Revenue [Line Items]
Total net revenues	67		67
Photonics
Disaggregation of Revenue [Line Items]
Total net revenues	12,198	9,183	35,323	24,116
Photonics | Products Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total net revenues	574	573	1,649	1,944
Photonics | Products and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total net revenues	11,624	8,610	33,674	22,172
Photonics | United States
Disaggregation of Revenue [Line Items]
Total net revenues	12,079	9,050	35,060	23,578
Photonics | Asia
Disaggregation of Revenue [Line Items]
Total net revenues
Photonics | Europe
Disaggregation of Revenue [Line Items]
Total net revenues	$ 119	$ 133	$ 263	$ 538

XML

Revenue - Changes in Contract Assets and Contract Liabilities (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 26, 2020	Dec. 28, 2019
TFE
Contract liabilities:
Contract liabilities	$ 1,450	$ 4,327
Contract liabilities:
Change in contract liabilities	(2,877)
TFE | Accounts Receivable, Unbilled
Contract assets:
Contract assets	560	760
Contract assets:
Change in contract assets	(200)
TFE | Deferred Revenue
Contract liabilities:
Contract liabilities	399	320
Contract liabilities:
Change in contract liabilities	79
TFE | Customer Advances
Contract liabilities:
Contract liabilities	1,051	4,007
Contract liabilities:
Change in contract liabilities	(2,956)
Photonics
Contract assets:
Contract assets	3,361	3,309
Contract assets:
Change in contract assets	52
Photonics | Accounts Receivable, Unbilled
Contract assets:
Contract assets	3,238	3,210
Contract assets:
Change in contract assets	28
Photonics | Deferred Revenue
Contract liabilities:
Contract liabilities	31
Contract liabilities:
Change in contract liabilities	31
Photonics | Retainage
Contract assets:
Contract assets	123	$ 99
Contract assets:
Change in contract assets	$ 24

XML

Revenue - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 26, 2020 USD ($) Installment
Revenue From Contract With Customers [Line Items]
Revenue remaining performance obligation	$ 63,300
TFE
Revenue From Contract With Customers [Line Items]
Revenue remaining performance obligation	$ 18,100
TFE | Accounts Receivable, Unbilled
Revenue From Contract With Customers [Line Items]
Number of installments | Installment	3
Change in contract assets	$ (200)
TFE | Customer Advances
Revenue From Contract With Customers [Line Items]
Contract with customer liability revenue recognized	4,000
TFE | Deferred Revenue
Revenue From Contract With Customers [Line Items]
Contract with customer liability revenue recognized	119
Photonics
Revenue From Contract With Customers [Line Items]
Change in contract assets	52
Revenue remaining performance obligation	45,200
Photonics | Accounts Receivable, Unbilled
Revenue From Contract With Customers [Line Items]
Change in contract assets	$ 28

XML

Revenue - Additional Information (Detail 1)	Sep. 26, 2024	Sep. 26, 2023	Sep. 26, 2022	Sep. 26, 2021	Sep. 26, 2020
Revenue From Contract With Customers [Line Items]
Revenue, remaining performance obligation, percentage					42.00%
Scenario Forecast
Revenue From Contract With Customers [Line Items]
Revenue, remaining performance obligation, percentage	1.00%	9.00%	18.00%	30.00%

XML

Inventories - Inventories Stated at Lower of Average Cost or Net Realizable Value (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 11,166	$ 15,286
Work-in-progress	5,732	4,748
Finished goods	6,740	4,873
Inventories	$ 23,638	$ 24,907

XML

Equity-Based Compensation - Additional information (Detail) - USD ($)		1 Months Ended	3 Months Ended	9 Months Ended
	Aug. 01, 2020	May 31, 2020	Jun. 29, 2019	Sep. 26, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase of common stock through payroll deductions				85.00%
Offering periods				2 years
Maximum employee salary withholdings for purchase of common stock under the terms of the ESPP	50.00%
Options granted under performance stock options				6,000
Stock issued under Employee Stock Purchase Plans				392,088
Employee stock obligation amount	$ 25,000
Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted under performance stock options			37,500
Performance stock option vesting period				1 year 1 month 6 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period				4 years
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage		100.00%
Granted		109,465		658,090

XML

Equity-Based Compensation - Effect of Recording Equity-Based Compensation (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	$ 858	$ 751	$ 2,186	$ 2,260
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	47	213	411	610
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	495	375	1,311	1,018
ESPP awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	$ 316	$ 163	$ 464	$ 632

XML

Equity-Based Compensation - Weighted-Average Fair Value of Stock Options and Employee Stock Purchase Rights using Weighted-Average Assumptions (Detail) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average fair value of grants per share	$ 0	$ 1.84	$ 1.82	$ 2.05
Expected volatility	0.00%	43.87%	46.04%	43.22%
Risk free interest rate	0.00%	1.57%	0.44%	1.86%
Expected term of options (in years)		4 years 3 months 25 days	4 years 4 months 20 days	4 years 6 months 21 days
Dividend yield	0.00%	0.00%	0.00%	0.00%
Stock Purchase Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average fair value of grants per share	$ 2.20	$ 1.45	$ 2.20	$ 1.73
Expected volatility	51.72%	38.27%	51.49%	45.81%
Risk free interest rate	0.12%	1.85%	0.14%	2.28%
Expected term of options (in years)	1 year 3 months 3 days	9 months	1 year 2 months 26 days	10 months 28 days
Dividend yield	0.00%	0.00%	0.00%	0.00%

XML

Equity-Based Compensation - Weighted-Average Fair Value of Performance Stock Options Using Weighted-Average Assumptions (Detail) - $ / shares	9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019
Performance Stock Options (PSO's)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average fair value of grants per share		$ 1.75
Expected volatility		43.43%
Risk free interest rate		1.96%
Expected term (in years)		4 years 7 months 6 days
Dividend yield		0.00%
Performance Based Restricted Stock Units (PRSU's)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average fair value of grants per share	$ 3.16
Expected volatility	46.70%
Risk free interest rate	0.25%
Dividend yield	0.00%

XML

Equity-Based Compensation - Option Activity and Changes (Detail)	9 Months Ended
	Sep. 26, 2020 $ / shares shares
Shares
Options outstanding at December 28, 2019 | shares	2,096,610
Options granted | shares	6,000
Options cancelled and forfeited | shares	(193,461)
Options exercised | shares	(61,722)
Options outstanding at September 26, 2020 | shares	1,847,427
Options exercisable at September 26, 2020 | shares	1,395,582
Weighted-Average Exercise Price
Options outstanding at December 28, 2019 | $ / shares	$ 6.63
Options granted | $ / shares	4.88
Options cancelled and forfeited | $ / shares	6.68
Options exercised | $ / shares	4.77
Options outstanding at September 26, 2020 | $ / shares	6.68
Options exercisable at September 26, 2020 | $ / shares	$ 6.80

XML

Equity-Based Compensation - Summary of Restricted Stock Units Activity (Detail) - Restricted Stock Units (RSUs) - $ / shares	1 Months Ended	9 Months Ended
	May 31, 2020	Sep. 26, 2020
Shares
Non-vested RSUs at December 28, 2019		553,355
Granted	109,465	658,090
Vested		(221,483)
Cancelled		(35,815)
Non-vested RSUs at September 26, 2020		954,147
Weighted Average Grant Date Fair Value
Non-vested RSUs at December 28, 2019		$ 6.15
Granted		4.85
Vested		6.51
Cancelled		6.05
Non-vested RSUs at September 26, 2020		$ 5.17

XML

Purchased Intangible Assets - Additional Information (Detail)	3 Months Ended	9 Months Ended
	Sep. 26, 2020 USD ($)	Sep. 26, 2020 USD ($)
Business Combination Segment Allocation [Line Items]
Total amortization expense of finite-lived intangibles	$ 11,000	$ 270,000
Purchased Intangible Assets, future amortization expense	$ 4,000	$ 4,000

XML

Purchased Intangible Assets - Details of Finite-lived Intangible Assets by Segment (Detail) $ in Thousands	Sep. 26, 2020 USD ($)
Finite-Lived Intangible Assets [Line Items]
Finite Lived, Gross Carrying Amount	$ 8,387
Accumulated Amortization	(8,383)
Finite Lived, Net Carrying Amount	4
TFE
Finite-Lived Intangible Assets [Line Items]
Finite Lived, Gross Carrying Amount	7,172
Accumulated Amortization	(7,172)
Finite Lived, Net Carrying Amount	0
Photonics
Finite-Lived Intangible Assets [Line Items]
Finite Lived, Gross Carrying Amount	1,215
Accumulated Amortization	(1,211)
Finite Lived, Net Carrying Amount	$ 4

XML

Acquisition-Related Contingent Consideration - Additional Information (Detail) $ in Millions	Nov. 19, 2010 USD ($)
Solar Implant Technologies | Revenue Earnout
Business Acquisition [Line Items]
Maximum amount of cash potentially earned in contingent compensation arrangements	$ 9.0

XML

Acquisition-Related Contingent Consideration - Reconciliation of Change in Fair Value Measurement of Contingent Consideration Liability (Detail) $ in Thousands	9 Months Ended
	Sep. 28, 2019 USD ($)
Business Combinations [Abstract]
Beginning balance	$ 223
Changes in fair value	7
Cash payments made	(230)
Ending balance

XML

Warranty - Additional Information (Detail)	9 Months Ended
	Sep. 26, 2020
Guarantees [Abstract]
Minimum product warranty range	12 months
Maximum product warranty range	24 months

XML

Warranty - Activity in Warranty Provision Account (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Guarantees [Abstract]
Opening balance	$ 662	$ 948	$ 1,022	$ 997
Expenditures incurred under warranties	(89)	(167)	(398)	(592)
Accruals for product warranties issued during the reporting period	39	427	198	829
Adjustments to previously existing warranty accruals	(57)	(72)	(267)	(98)
Closing balance	$ 555	$ 1,136	$ 555	$ 1,136

XML

Warranty - Balance Sheet Classification of Warranty Provision Account (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Jun. 27, 2020	Dec. 28, 2019	Sep. 28, 2019	Jun. 29, 2019	Dec. 29, 2018
Guarantees [Abstract]
Other accrued liabilities	$ 425		$ 846
Other long-term liabilities	130		176
Total warranty provision	$ 555	$ 662	$ 1,022	$ 1,136	$ 948	$ 997

XML

Guarantees - Additional Information (Detail)	Sep. 26, 2020 USD ($)
Guarantees [Abstract]
Letters of credit and bank guarantees outstanding, amount	$ 787,000
Letters of credit and bank guarantees collateralized by restricted cash	$ 787,000

XML

Cash, Cash Equivalents and Investments - Cash, Cash Equivalents and Short-Term Investments and Long-Term Investments (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 48,589	$ 41,981
Unrealized Holding Gains	72	43
Unrealized Holding Losses		0
Fair Value	48,661	42,024
Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	27,245	19,767
Fair Value	27,245	19,767
Cash and Cash Equivalents | Cash
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	23,829	16,512
Fair Value	23,829	16,512
Cash and Cash Equivalents | Money market funds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,416	3,255
Fair Value	3,416	3,255
Short-term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	18,272	16,691
Unrealized Holding Gains	70	29
Unrealized Holding Losses		0
Fair Value	18,342	16,720
Short-term Investments | Corporate bonds and medium-term notes
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,842	6,383
Unrealized Holding Gains	27	25
Unrealized Holding Losses		0
Fair Value	3,869	6,408
Short-term Investments | U.S. treasury and agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	6,481	5,417
Unrealized Holding Gains	35	1
Fair Value	6,516	5,418
Short-term Investments | Certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	7,450	3,000
Unrealized Holding Gains	7	1
Unrealized Holding Losses		0
Fair Value	7,457	3,001
Short-term Investments | Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	499	1,891
Unrealized Holding Gains	1	2
Unrealized Holding Losses		0
Fair Value	500	1,893
Long-term Investments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,072	5,523
Unrealized Holding Gains	2	14
Unrealized Holding Losses		0
Fair Value	3,074	5,537
Long-term Investments | Corporate bonds and medium-term notes
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,572	2,530
Unrealized Holding Gains	2	12
Unrealized Holding Losses		0
Fair Value	2,574	2,542
Long-term Investments | U.S. treasury and agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		2,494
Unrealized Holding Gains		1
Unrealized Holding Losses		0
Fair Value		2,495
Long-term Investments | Certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	500	499
Unrealized Holding Gains		1
Unrealized Holding Losses
Fair Value	$ 500	$ 500

XML

Cash, Cash Equivalents and Investments - Contractual Maturities of Available-For-Sale Securities (Detail) $ in Thousands	Sep. 26, 2020 USD ($)
Investments Debt And Equity Securities [Abstract]
Amortized Cost, Due in one year or less	$ 21,688
Amortized Cost, Due after one through five years	3,072
Amortized Cost	24,760
Fair Value, Due in one year or less	21,758
Fair Value, Due after one through five years	3,074
Fair Value	$ 24,832

XML

Cash, Cash Equivalents and Investments - Fair Value Hierarchy of Available-for-Sale Securities Measured at Fair Value on Recurring Basis (Detail) $ in Thousands	Sep. 26, 2020 USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	$ 24,832
Fair Value, Measurements, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	24,832
Fair Value, Measurements, Recurring | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	3,416
Fair Value, Measurements, Recurring | Certificates of deposit
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	7,957
Fair Value, Measurements, Recurring | Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	500
Fair Value, Measurements, Recurring | U.S. treasury and agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	6,516
Fair Value, Measurements, Recurring | Corporate bonds and medium-term notes
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	6,443
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	9,932
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	3,416
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | U.S. treasury and agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	6,516
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	14,900
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Certificates of deposit
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	7,957
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	500
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Corporate bonds and medium-term notes
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total recurring fair value measurements	$ 6,443

XML

Derivative Instruments - Additional Information (Detail)	9 Months Ended
	Sep. 26, 2020
Derivative Instrument Detail [Abstract]
Maturity of foreign currency derivative	30 days

XML

Derivative Instruments - Summary of Outstanding Derivative Instruments on Gross Basis as Recorded in Consolidated Balance Sheets (Detail) - Undesignated Hedges - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Derivatives, Fair Value [Line Items]
Notional Amounts	$ 871	$ 1,035
Derivative Liabilities	5	4
Forward Foreign Currency Contracts
Derivatives, Fair Value [Line Items]
Notional Amounts	871	1,035
Derivative Liabilities	$ 5	$ 4

XML

Equity - Schedule of Changes in Stockholders' Equity (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Class of Stock [Line Items]
Beginning balance	$ 97,655	$ 88,347	$ 95,793	$ 89,624
Common stock issued under employee plans	871	749	1,865	1,770
Shares withheld for net share settlement of RSUs	(19)	(28)	(364)	(296)
Equity-based compensation expense	858	751	2,186	2,260
Net income (loss)	(357)	(480)	(57)	(4,054)
Other comprehensive loss	100	(84)	78	(7)
Common stock repurchases	0	(69)	(393)	(111)
Ending balance	99,108	89,186	99,108	89,186
Common Stock and Additional Paid-in Capital
Class of Stock [Line Items]
Beginning balance	190,290	185,489	188,313	183,227
Common stock issued under employee plans	871	749	1,865	1,770
Shares withheld for net share settlement of RSUs	(19)	(28)	(364)	(296)
Equity-based compensation expense	858	751	2,186	2,260
Ending balance	192,000	186,961	192,000	186,961
Treasury Stock
Class of Stock [Line Items]
Beginning balance	(29,551)	(29,089)	(29,158)	(29,047)
Common stock repurchases		(69)	(393)	(111)
Ending balance	(29,551)	(29,158)	(29,551)	(29,158)
Accumulated Other Comprehensive Income
Class of Stock [Line Items]
Beginning balance	402	455	424	378
Other comprehensive loss	100	(84)	78	(7)
Ending balance	502	371	502	371
Accumulated Deficit
Class of Stock [Line Items]
Beginning balance	(63,486)	(68,508)	(63,786)	(64,934)
Net income (loss)	(357)	(480)	(57)	(4,054)
Ending balance	$ (63,843)	$ (68,988)	$ (63,843)	$ (68,988)

XML

Equity - Changes in Accumulated Other Comprehensive Income by Component (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ 97,655	$ 88,347	$ 95,793	$ 89,624
Other comprehensive income (loss), net of tax	100	(84)	78	(7)
Ending balance	99,108	89,186	99,108	89,186
Foreign currency
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	306	405	381	405
Other comprehensive income (loss) before reclassification	124	(87)	49	(87)
Other comprehensive income (loss), net of tax	124	(87)	49	(87)
Ending balance	430	318	430	318
Unrealized holding gains (losses) on available- for-sale investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	96	50	43	(27)
Other comprehensive income (loss) before reclassification	(24)	3	29	80
Other comprehensive income (loss), net of tax	(24)	3	29	80
Ending balance	72	53	72	53
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	402	455	424	378
Other comprehensive income (loss) before reclassification	100	(84)	78	(7)
Other comprehensive income (loss), net of tax	100	(84)	78	(7)
Ending balance	$ 502	$ 371	$ 502	$ 371

XML

Equity - Additional Information (Detail) - USD ($) $ in Millions	Aug. 15, 2018	Sep. 26, 2020	Nov. 21, 2013
Equity [Abstract]
Stock repurchase authorized amount	$ 40.0		$ 30.0
Increase in stock repurchase program	$ 10.0
Stock repurchase remained available for future stock repurchase		$ 10.4

XML

Equity - Schedule of Stock Repurchases (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Equity [Abstract]
Shares of common stock repurchased	0	15	98	24
Cost of stock repurchased	$ 0	$ 69	$ 393	$ 111
Average price paid per share	$ 0	$ 4.65	$ 3.97	$ 4.67

XML

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Earnings Per Share [Abstract]
Net loss	$ (357)	$ (480)	$ (57)	$ (4,054)
Weighted-average shares – basic	23,771	23,130	23,605	22,992
Effect of dilutive potential common shares	0	0	0	0
Weighted-average shares – diluted	23,771	23,130	23,605	22,992
Net loss per share – basic	$ (0.02)	$ (0.02)	$ 0.00	$ (0.18)
Net loss per share – diluted	$ (0.02)	$ (0.02)	$ 0.00	$ (0.18)

XML

Segment Reporting - Additional Information (Detail)	9 Months Ended
	Sep. 26, 2020 Segment
Segment Reporting [Abstract]
Number of reportable segments	2
Allocation of corporate expenses to the segments	3.00%

XML

Segment Reporting - Information for Each Reportable Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019
Segment Reporting Information [Line Items]
Total segment net revenues	$ 21,565	$ 26,299	$ 69,248	$ 73,441
Operating income (loss)	(148)	(433)	856	(3,358)
Interest income	8	126	212	448
Income (loss) before provision for income taxes	(140)	(307)	1,068	(2,910)
TFE
Segment Reporting Information [Line Items]
Total segment net revenues	9,367	17,116	33,925	49,325
Photonics
Segment Reporting Information [Line Items]
Total segment net revenues	12,198	9,183	35,323	24,116
Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	1,371	726	5,114	(320)
Operating Segments | TFE
Segment Reporting Information [Line Items]
Operating income (loss)	(1,661)	(1,542)	(4,366)	(3,434)
Operating Segments | Photonics
Segment Reporting Information [Line Items]
Operating income (loss)	3,032	2,268	9,480	3,114
Unallocated Amount to Segment
Segment Reporting Information [Line Items]
Unallocated costs	$ (1,519)	$ (1,159)	$ (4,258)	$ (3,038)

XML

Segment Reporting - Assets for Each Reportable Segment (Detail) - USD ($) $ in Thousands	Sep. 26, 2020	Dec. 28, 2019
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	$ 124,369	$ 126,322
Cash and investments	48,661	42,024
Restricted cash	787	787
Deferred income taxes	5,736	6,252
Other current assets	1,145	752
Common property, plant and equipment	1,461	1,307
Common operating lease right-of-use assets	1,711	1,898
Other assets	0	78
Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	64,868	73,224
Operating Segments | TFE
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	45,819	51,153
Operating Segments | Photonics
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	$ 19,049	$ 22,071

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 31, 2020	Sep. 26, 2020	Sep. 28, 2019	Sep. 26, 2020	Sep. 28, 2019	Dec. 29, 2020	Dec. 31, 2020
Government Grants [Line Items]
Provision for income taxes		$ 217	$ 173	$ 1,125	$ 1,144
Income tax provision on earnings of subsidiaries		111	48	659	611
Deferred payroll tax liability		547		547			$ 763
Proceeds from Income Tax Refunds	$ 157
Proceeds From Government Grants		124		434
Grant [Member] | Cost of Sales [Member]
Government Grants [Line Items]
Proceeds From Government Grants		72		252
Grant [Member] | Research and Development Expense [Member]
Government Grants [Line Items]
Proceeds From Government Grants		20		68
Grant [Member] | Selling, General and Administrative Expenses [Member]
Government Grants [Line Items]
Proceeds From Government Grants		32		114
Forecast [Member]
Government Grants [Line Items]
Proceeds From Government Grants						$ 554
Inland Revenue, Singapore (IRAS)
Government Grants [Line Items]
Deposit for contested taxes and related interest		915		915
Foreign Tax Authority | Singapore
Government Grants [Line Items]
Income tax charge (benefit)		$ 98	$ 130	$ 471	$ 534

XML

Restructuring Charges - Additional Information (Detail) $ in Thousands	3 Months Ended
	Sep. 26, 2020 USD ($)
Restructuring and Related Activities [Abstract]
Percentage of reduction of global workforce	1.00%
Reduction in salary, wages and other employee-related expenses due to implementation of plan	$ 864

XML

Restructuring Charges - Changes in Restructuring Reserves (Detail) - Severance and Other Employee Related Costs $ in Thousands	9 Months Ended
	Sep. 26, 2020 USD ($)
Restructuring Cost and Reserve [Line Items]
Provision for restructuring reserves	$ 103
Cash payments made	$ (103)